data_2hqi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hqi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.638 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 3.5 tm0? . . . . . 0 C--O 1.212 -0.885 0 CA-C-O 121.643 0.735 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LYS . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.516 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.587 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 ' CG1' ' A' ' 45' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 28' ' ' VAL . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.504 ' N ' HG21 ' A' ' 34' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' ASP . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.488 ' O ' ' OG1' ' A' ' 61' ' ' THR . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.587 ' CD2' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.485 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.243 1.02 . . . . 0.0 111.637 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.558 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.571 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.528 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.593 HG13 ' CG ' ' A' ' 38' ' ' PHE . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HB3' ' CB ' ' A' ' 51' ' ' LYS . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' LEU . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG22 ' CG1' ' A' ' 45' ' ' VAL . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.552 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 32' ' ' SER . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CE1' ' CG2' ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.621 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 58' ' ' THR . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.567 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 122.537 1.161 . . . . 0.0 112.224 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 71' ' ' LYS . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.633 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.557 ' O ' ' CG2' ' A' ' 13' ' ' THR . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.557 ' CG2' ' O ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.633 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.565 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' CG1' ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.58 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' HG23 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' O ' HG11 ' A' ' 36' ' ' VAL . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 35' ' ' ASP . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG1' HG22 ' A' ' 36' ' ' VAL . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.538 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.468 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.632 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.607 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.537 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.501 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 122.385 1.088 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.536 ' CA ' HG21 ' A' ' 46' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 71' ' ' LYS . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.48 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.495 HG21 ' N ' ' A' ' 20' ' ' THR . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.588 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 66' ' ' TYR . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 36' ' ' VAL . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.55 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' HG11 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' CA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.545 ' CG1' HG22 ' A' ' 36' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' N ' ' A' ' 33' ' ' LYS . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CZ ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.512 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.597 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 122.268 1.033 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HD13 ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.462 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.49 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.562 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 66' ' ' TYR . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' ' CG ' ' A' ' 27' ' ' LYS . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 45' ' ' VAL . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.526 ' CB ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.562 ' CB ' ' N ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG21 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.645 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' OG ' ' A' ' 53' ' ' SER . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.645 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.434 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CD2' ' OG1' ' A' ' 20' ' ' THR . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 122.134 0.968 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' LYS . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.521 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.508 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 67' ' ' PRO . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.59 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 26' ' ' SER . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 45' ' ' VAL . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' HG11 ' A' ' 36' ' ' VAL . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.527 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.594 ' CG1' HG22 ' A' ' 36' ' ' VAL . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.656 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 49' ' ' ASP . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' ' CG2' ' A' ' 61' ' ' THR . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.558 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 122.531 1.158 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 46' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 43' ' ' ALA . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.592 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.617 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.618 ' CG1' ' CD2' ' A' ' 38' ' ' PHE . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 67' ' ' PRO . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 ' CD1' HG23 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.538 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' CG ' ' HB3' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.494 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 22' ' ' LYS . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' HG11 ' A' ' 36' ' ' VAL . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.56 ' CG1' HG22 ' A' ' 36' ' ' VAL . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 32' ' ' SER . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.557 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.596 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.617 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.447 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 122.164 0.983 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 46' ' ' THR . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.555 ' O ' ' CG2' ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.574 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG21 ' CB ' ' A' ' 66' ' ' TYR . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.628 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.545 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG21 ' N ' ' A' ' 35' ' ' ASP . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 44' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.628 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 36' ' ' VAL . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.609 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.623 ' CG ' HD21 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.481 ' OD1' ' OG1' ' A' ' 50' ' ' THR . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 53' ' ' SER . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 58' ' ' THR . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HB3' ' HG3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.513 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 71' ' ' LYS . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 20.4 pt20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 122.306 1.05 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 46' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.504 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.535 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' ' HB3' ' A' ' 51' ' ' LYS . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.55 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 36' ' ' VAL . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG1' HG22 ' A' ' 36' ' ' VAL . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.55 HG22 ' CB ' ' A' ' 32' ' ' SER . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.542 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 58' ' ' THR . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.583 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.548 ' CA ' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.432 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HB3' ' CA ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.644 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 1.8 mp0 . . . . . 0 C--O 1.21 -0.983 0 CA-C-O 121.807 0.813 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' CG2' ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.556 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.52 ' HA ' ' CB ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.596 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.579 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 67' ' ' PRO . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.552 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.567 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' HD23 ' A' ' 7' ' ' LEU . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.528 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 28' ' ' VAL . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.662 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.414 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.662 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.526 ' CB ' ' HA ' ' A' ' 67' ' ' PRO . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.532 ' CA ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 122.341 1.067 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' HB1' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.498 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.58 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.557 ' CB ' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HA ' ' CG ' ' A' ' 27' ' ' LYS . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 43' ' ' ALA . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.586 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 26' ' ' SER . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.466 ' O ' HG21 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' N ' ' A' ' 46' ' ' THR . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG11 ' A' ' 45' ' ' VAL . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.543 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' N ' ' OG ' ' A' ' 53' ' ' SER . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.643 ' CD2' ' CG ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 58' ' ' THR . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.533 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.458 ' OG ' HD21 ' A' ' 7' ' ' LEU . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 HG21 ' N ' ' A' ' 71' ' ' LYS . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.485 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 121.768 0.794 . . . . 0.0 109.023 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.578 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.528 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' HB ' ' CD2' ' A' ' 57' ' ' LEU . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CB ' ' HB3' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.578 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 9' ' ' VAL . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' ASP . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.603 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.668 ' CD1' ' CD1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 58' ' ' THR . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.413 ' C ' HG23 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.459 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.21 -0.997 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' ' CG2' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 71' ' ' LYS . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.537 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 12' ' ' MET . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.561 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 20' ' ' THR . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.588 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 ' CG1' ' OG ' ' A' ' 68' ' ' SER . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.64 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.562 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' HG13 ' A' ' 45' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.64 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 35' ' ' ASP . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.577 ' CG1' HG22 ' A' ' 36' ' ' VAL . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 48' ' ' ASP . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 HG21 ' HA2' ' A' ' 30' ' ' GLY . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' O ' ' OG1' ' A' ' 58' ' ' THR . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 58' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.602 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.588 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.205 1.002 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' LYS . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.538 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 38' ' ' PHE . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.589 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' C ' ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.544 ' CG ' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 26' ' ' SER . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' N ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' O ' HG11 ' A' ' 36' ' ' VAL . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' ASP . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' CG1' HG22 ' A' ' 36' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.535 ' N ' ' HB3' ' A' ' 33' ' ' LYS . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.544 ' CB ' ' CG ' ' A' ' 29' ' ' GLU . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 29' ' ' GLU . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.523 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 58' ' ' THR . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.28 0.562 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.604 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -51.49 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.638 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 3.5 tm0? -127.03 89.4 2.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.082 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 71' ' ' LYS . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.516 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.587 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.537 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.533 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 ' CG1' ' A' ' 45' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 28' ' ' VAL . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.553 ' HA ' HG11 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' N ' HG21 ' A' ' 34' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 35' ' ' ASP . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.471 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.484 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.488 ' O ' ' OG1' ' A' ' 61' ' ' THR . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.587 ' CD2' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.53 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.485 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.541 ' HA ' ' N ' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -44.03 125.14 4.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 108.92 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.46 156.09 31.52 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.081 -1.447 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.558 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.571 ' HB ' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.528 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.593 HG13 ' CG ' ' A' ' 38' ' ' PHE . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.571 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HB3' ' CB ' ' A' ' 51' ' ' LYS . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 25' ' ' LEU . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' ' CG2' ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 HG23 ' N ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG22 ' CG1' ' A' ' 45' ' ' VAL . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.552 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.579 ' CG2' ' CD1' ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 32' ' ' SER . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CE1' ' CG2' ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' N ' ' HA ' ' A' ' 2' ' ' THR . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 48' ' ' ASP . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.621 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 58' ' ' THR . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.567 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.581 ' CD2' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.551 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 29.49 95.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.252 -0.28 . . . . 0.0 110.535 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -165.31 168.08 17.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.851 -1.54 . . . . 0.0 112.224 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.545 ' O ' ' CG2' ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 71' ' ' LYS . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.633 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.557 ' O ' ' CG2' ' A' ' 13' ' ' THR . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.557 ' CG2' ' O ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.549 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.633 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.565 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' CG1' ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.58 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 28' ' ' VAL . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' CD1' HG23 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.579 ' HA ' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' O ' HG11 ' A' ' 36' ' ' VAL . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 35' ' ' ASP . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG1' HG22 ' A' ' 36' ' ' VAL . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.545 ' HB3' ' CB ' ' A' ' 2' ' ' THR . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.538 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.468 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.632 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.607 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.537 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.501 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' HG13 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -51.69 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.994 -0.441 . . . . 0.0 109.894 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -168.17 -169.2 1.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.507 -1.37 . . . . 0.0 111.224 -179.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.536 ' CA ' HG21 ' A' ' 46' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.526 ' O ' ' N ' ' A' ' 71' ' ' LYS . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.48 ' HB3' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.583 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.495 HG21 ' N ' ' A' ' 20' ' ' THR . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.588 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 66' ' ' TYR . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.597 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 36' ' ' VAL . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.55 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.595 ' CG2' ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HA ' HG11 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' CA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.545 ' CG1' HG22 ' A' ' 36' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' N ' ' A' ' 33' ' ' LYS . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.64 ' CZ ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' N ' ' OG1' ' A' ' 2' ' ' THR . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.512 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.597 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 34.79 41.15 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.364 0.602 . . . . 0.0 109.657 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -168.41 -168.15 0.89 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.652 -1.28 . . . . 0.0 110.534 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HD13 ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.462 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.49 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.562 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG21 ' CB ' ' A' ' 66' ' ' TYR . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' ' CG ' ' A' ' 27' ' ' LYS . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 45' ' ' VAL . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.515 ' OG ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.526 ' CB ' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.562 ' CB ' ' N ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG21 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.645 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' N ' ' OG ' ' A' ' 53' ' ' SER . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.645 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.578 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.55 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.434 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CD2' ' OG1' ' A' ' 20' ' ' THR . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.524 ' CA ' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -43.21 126.02 3.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.39 161.57 18.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.771 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 71' ' ' LYS . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 69' ' ' SER . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.582 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.521 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.542 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.508 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 67' ' ' PRO . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.59 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD1' HG23 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 26' ' ' SER . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG22 ' CG1' ' A' ' 45' ' ' VAL . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' O ' HG11 ' A' ' 36' ' ' VAL . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.527 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.594 ' CG1' HG22 ' A' ' 36' ' ' VAL . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.656 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 49' ' ' ASP . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.547 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.591 ' CD2' ' CD2' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.552 ' O ' ' CG2' ' A' ' 61' ' ' THR . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.558 ' HB ' ' CB ' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.552 ' HA ' ' N ' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -41.26 122.38 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.79 . . . . 0.0 109.341 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 154.12 16.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 117.757 -1.577 . . . . 0.0 112.014 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 46' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 43' ' ' ALA . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.592 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' HD11 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.617 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.618 ' CG1' ' CD2' ' A' ' 38' ' ' PHE . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 67' ' ' PRO . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.567 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 ' CD1' HG23 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.538 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' CG ' ' HB3' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.494 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 22' ' ' LYS . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' O ' HG11 ' A' ' 36' ' ' VAL . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 35' ' ' ASP . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.56 ' CG1' HG22 ' A' ' 36' ' ' VAL . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 32' ' ' SER . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.62 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' N ' ' HA ' ' A' ' 2' ' ' THR . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.557 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.596 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 ' CG ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.617 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.447 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 49' ' ' ASP . 8.0 t 38.43 31.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -168.11 -168.62 0.98 Allowed 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.659 -178.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 46' ' ' THR . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' CG1' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.555 ' O ' ' CG2' ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.574 ' HB2' ' HA ' ' A' ' 38' ' ' PHE . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG21 ' CB ' ' A' ' 66' ' ' TYR . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.628 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 23' ' ' LYS . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.545 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG21 ' N ' ' A' ' 35' ' ' ASP . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 44' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.574 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' O ' HG11 ' A' ' 36' ' ' VAL . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.609 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 33' ' ' LYS . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.623 ' CG ' HD21 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' OD1' ' OG1' ' A' ' 50' ' ' THR . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.542 ' N ' ' OG ' ' A' ' 53' ' ' SER . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' CG ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 58' ' ' THR . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' HB3' ' HG3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.531 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 71' ' ' LYS . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -46.08 121.78 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.013 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 20.4 pt20 -161.17 153.64 20.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.072 -1.451 . . . . 0.0 111.459 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 46' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.504 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.579 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.536 ' CD1' HG23 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.535 ' N ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.537 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CG ' ' HB3' ' A' ' 51' ' ' LYS . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.55 ' CB ' HG22 ' A' ' 46' ' ' THR . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.465 ' O ' HG11 ' A' ' 36' ' ' VAL . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' CB ' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG1' HG22 ' A' ' 36' ' ' VAL . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.55 HG22 ' CB ' ' A' ' 32' ' ' SER . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.542 ' HB2' ' N ' ' A' ' 2' ' ' THR . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.542 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.543 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HB ' ' CZ ' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 58' ' ' THR . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.583 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' CA ' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HB3' ' CA ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.574 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 1.5 t -65.83 170.16 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.644 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 1.8 mp0 -129.49 112.21 13.54 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.556 -1.34 . . . . 0.0 109.682 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.582 ' O ' ' CG2' ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.511 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.556 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.52 ' HA ' ' CB ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.596 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.579 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 67' ' ' PRO . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.552 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.567 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' CD2' HD23 ' A' ' 7' ' ' LEU . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.523 ' HB2' ' CG2' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.567 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.528 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 28' ' ' VAL . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.662 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.612 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.414 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' CG2' ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.662 ' CD1' ' CE1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.526 ' CB ' ' HA ' ' A' ' 67' ' ' PRO . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.532 ' CA ' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.532 ' HB3' ' CA ' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.577 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.543 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -41.7 127.94 3.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.412 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -159.26 153.74 24.14 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.118 -1.433 . . . . 0.0 111.85 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.534 ' O ' ' CG2' ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 69' ' ' SER . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' HB1' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.498 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.58 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.557 ' CB ' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HA ' ' CG ' ' A' ' 27' ' ' LYS . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD1' ' HB3' ' A' ' 43' ' ' ALA . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.586 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 26' ' ' SER . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.607 ' CB ' ' HA ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' O ' HG21 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' CB ' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG11 ' N ' ' A' ' 46' ' ' THR . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.549 ' N ' HG11 ' A' ' 45' ' ' VAL . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' HB2' ' N ' ' A' ' 2' ' ' THR . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.543 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.532 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.549 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' N ' ' OG ' ' A' ' 53' ' ' SER . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.643 ' CD2' ' CG ' ' A' ' 47' ' ' PHE . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 58' ' ' THR . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.458 ' OG ' HD21 ' A' ' 7' ' ' LEU . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 HG21 ' N ' ' A' ' 71' ' ' LYS . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.485 ' HG3' ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.584 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.635 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 5.0 t 45.27 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.878 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -130.12 89.18 2.76 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.303 -1.498 . . . . 0.0 109.023 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.542 ' CB ' ' O ' ' A' ' 69' ' ' SER . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.578 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.586 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.469 ' O ' HD13 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.528 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' HB ' ' CD2' ' A' ' 57' ' ' LEU . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' CB ' ' HB3' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.46 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.525 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.578 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' C ' HG22 ' A' ' 9' ' ' VAL . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' ASP . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.603 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.635 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.457 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.668 ' CD1' ' CD1' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 58' ' ' THR . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.413 ' C ' HG23 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.459 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.587 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -46.78 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.591 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -119.84 89.64 3.17 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 120.767 -1.208 . . . . 0.0 108.743 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' ' CG2' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.563 ' O ' ' N ' ' A' ' 71' ' ' LYS . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' CB ' ' O ' ' A' ' 69' ' ' SER . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' O ' ' HG3' ' A' ' 12' ' ' MET . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.561 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.525 ' CB ' ' O ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.574 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.455 ' CG2' ' N ' ' A' ' 20' ' ' THR . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.588 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 ' CG1' ' OG ' ' A' ' 68' ' ' SER . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.64 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD12 HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.562 ' CB ' ' HB1' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 28' ' ' VAL . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' HA ' HG13 ' A' ' 45' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.64 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 35' ' ' ASP . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.577 ' CG1' HG22 ' A' ' 36' ' ' VAL . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 48' ' ' ASP . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 HG21 ' HA2' ' A' ' 30' ' ' GLY . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' CB ' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' O ' ' OG1' ' A' ' 58' ' ' THR . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 58' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.602 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 67' ' ' PRO . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.588 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.5 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.535 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 1.3 t -38.13 109.06 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.663 -0.648 . . . . 0.0 109.665 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -165.34 149.95 8.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.351 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 71' ' ' LYS . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.552 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG1' ' HB3' ' A' ' 18' ' ' PRO . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.538 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 38' ' ' PHE . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 67' ' ' PRO . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.589 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' O ' ' CG2' ' A' ' 28' ' ' VAL . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' C ' ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.544 ' CG ' ' CB ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 26' ' ' SER . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' N ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 26' ' ' SER . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' O ' HG11 ' A' ' 36' ' ' VAL . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HA ' ' CG2' ' A' ' 36' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' ASP . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' CG1' HG22 ' A' ' 36' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.535 ' N ' ' HB3' ' A' ' 33' ' ' LYS . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB2' ' N ' ' A' ' 2' ' ' THR . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.544 ' CB ' ' CG ' ' A' ' 29' ' ' GLU . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 29' ' ' GLU . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' HD22 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.635 ' CG2' ' CE1' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HA ' ' CG1' ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.523 ' N ' ' CD1' ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 58' ' ' THR . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.547 ' CB ' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.641 ' HB3' ' CD2' ' A' ' 47' ' ' PHE . 3.5 tm0? . . . . . 0 C--O 1.212 -0.885 0 CA-C-O 121.643 0.735 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 4' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.872 HG23 HG22 ' A' ' 44' ' ' VAL . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.824 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.601 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG11 ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 1.021 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.818 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.935 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 26' ' ' SER . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.919 HG21 ' CD1' ' A' ' 25' ' ' LEU . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.872 HG22 HG23 ' A' ' 6' ' ' THR . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.054 ' O ' HG23 ' A' ' 61' ' ' THR . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.054 HG23 ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.243 1.02 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.988 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.819 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 16' ' ' ALA . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.59 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.819 HG11 ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.692 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.931 HD21 HD22 ' A' ' 7' ' ' LEU . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.927 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 28' ' ' VAL . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 28' ' ' VAL . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.927 HG21 ' CA ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG22 ' CA ' ' A' ' 43' ' ' ALA . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.895 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.988 ' CG2' HD13 ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 46' ' ' THR . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.954 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.954 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.969 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.881 ' N ' HD12 ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 57' ' ' LEU . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.698 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 122.537 1.161 . . . . 0.0 112.224 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.652 ' H ' HG12 ' A' ' 5' ' ' VAL . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.574 ' HE2' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 1.083 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.974 ' CD1' HG21 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.69 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.974 HG21 ' CD1' ' A' ' 25' ' ' LEU . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.584 ' CA ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 42' ' ' GLU . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 6' ' ' THR . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.726 HG11 HD13 ' A' ' 25' ' ' LEU . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.724 HG23 ' HB ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.533 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.898 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 57' ' ' LEU . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 58' ' ' THR . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.941 ' N ' HD12 ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 24' ' ' ALA . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.645 ' O ' HD23 ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 54' ' ' VAL . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 122.385 1.088 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 4' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.597 ' H ' HG12 ' A' ' 5' ' ' VAL . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.016 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 21' ' ' VAL . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.572 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.799 HG11 HG23 ' A' ' 9' ' ' VAL . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.016 ' CD2' HD22 ' A' ' 7' ' ' LEU . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.553 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.962 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CA ' ' A' ' 43' ' ' ALA . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CA ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.93 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 34' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.663 HG23 ' CA ' ' A' ' 4' ' ' THR . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.847 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.517 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.962 ' CB ' HG21 ' A' ' 28' ' ' VAL . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.781 HG22 ' HB1' ' A' ' 24' ' ' ALA . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.777 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.52 ' CB ' HD23 ' A' ' 7' ' ' LEU . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.798 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 122.268 1.033 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 4' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.094 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 14' ' ' CYS . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.718 HG11 HG13 ' A' ' 9' ' ' VAL . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.911 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.766 HD11 ' HB1' ' A' ' 43' ' ' ALA . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.993 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CD1' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.094 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 25' ' ' LEU . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.684 HG23 ' CA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG22 ' HE2' ' A' ' 47' ' ' PHE . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.993 ' HA ' HG21 ' A' ' 28' ' ' VAL . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.904 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.911 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.459 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' HG22 ' A' ' 58' ' ' THR . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 122.134 0.968 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 44' ' ' VAL . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.834 HD13 HG22 ' A' ' 45' ' ' VAL . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.92 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.538 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.785 HD12 ' HD2' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.519 ' HG1' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 HG13 ' A' ' 9' ' ' VAL . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.607 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.953 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.798 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' VAL . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG21 ' CA ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG21 ' CD1' ' A' ' 25' ' ' LEU . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.785 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 6' ' ' THR . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HD13 ' A' ' 7' ' ' LEU . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 46' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 57' ' ' LEU . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 49' ' ' ASP . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.604 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.028 ' HA ' HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.881 HG22 ' OG ' ' A' ' 68' ' ' SER . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.764 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.724 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.881 ' OG ' HG22 ' A' ' 58' ' ' THR . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.651 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 122.531 1.158 . . . . 0.0 112.014 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 4' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.948 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.948 HD12 ' HB1' ' A' ' 16' ' ' ALA . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.762 HG11 HG13 ' A' ' 9' ' ' VAL . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.588 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' CB ' HG22 ' A' ' 61' ' ' THR . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 43' ' ' ALA . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.028 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 6' ' ' THR . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.616 HG23 ' HB ' ' A' ' 4' ' ' THR . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.83 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.83 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.784 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' LEU . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 122.164 0.983 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.825 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.805 HD22 HD22 ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.967 HG23 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.561 ' C ' HG22 ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 9' ' ' VAL . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 61' ' ' THR . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 68' ' ' SER . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.57 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 1.054 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.471 ' C ' ' HG3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 45' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.892 HG21 ' CD1' ' A' ' 25' ' ' LEU . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 25' ' ' LEU . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 46' ' ' THR . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CE1' HD23 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 70' ' ' VAL . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.78 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.964 HG22 ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 57' ' ' LEU . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.797 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.786 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.964 ' O ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 54' ' ' VAL . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 11.7 pt20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 122.306 1.05 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.107 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.522 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.583 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.896 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.025 ' CD1' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.885 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.918 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.847 HG21 ' O ' ' A' ' 26' ' ' SER . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.885 HG21 ' CA ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' CD1' ' A' ' 25' ' ' LEU . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CD ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 46' ' ' THR . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.545 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HA ' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.918 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.906 ' N ' HD12 ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.896 HG22 ' HB1' ' A' ' 24' ' ' ALA . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.452 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.666 ' CD ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.21 -0.983 0 CA-C-O 121.807 0.813 . . . . 0.0 109.682 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 44' ' ' VAL . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.965 HD13 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.787 ' HB3' HG11 ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.708 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 9' ' ' VAL . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 1.115 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 45' ' ' VAL . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.115 HG23 ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.973 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 26' ' ' SER . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.684 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.045 HG22 HG23 ' A' ' 6' ' ' THR . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.965 HG22 HD13 ' A' ' 7' ' ' LEU . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.785 ' OD1' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.086 ' O ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.479 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.086 HG23 ' O ' ' A' ' 57' ' ' LEU . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.577 ' OG ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.647 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 47' ' ' PHE . 3.8 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 122.341 1.067 . . . . 0.0 111.85 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD22 ' A' ' 25' ' ' LEU . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB2' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.501 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 13' ' ' THR . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.783 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 9' ' ' VAL . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 28' ' ' VAL . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 25' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 1.001 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 34' ' ' VAL . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.599 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 33' ' ' LYS . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' HB ' ' A' ' 4' ' ' THR . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.552 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 58' ' ' THR . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.781 ' O ' HG23 ' A' ' 61' ' ' THR . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 57' ' ' LEU . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.852 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.852 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.761 ' CD ' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 121.768 0.794 . . . . 0.0 109.023 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 4' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.003 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 45' ' ' VAL . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.878 ' HB3' HG12 ' A' ' 9' ' ' VAL . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.604 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.89 HD13 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 1.03 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG21 HD13 ' A' ' 25' ' ' LEU . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.832 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 6' ' ' THR . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.031 HG22 HD13 ' A' ' 7' ' ' LEU . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.753 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.775 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.21 -0.997 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.009 HG23 HG22 ' A' ' 44' ' ' VAL . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.912 HD13 HG22 ' A' ' 45' ' ' VAL . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' GLY . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.679 ' C ' HG22 ' A' ' 13' ' ' THR . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.679 HG22 ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 16' ' ' ALA . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.595 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.669 HG11 HG13 ' A' ' 9' ' ' VAL . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.805 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.98 HG11 ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 26' ' ' SER . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG21 HD13 ' A' ' 25' ' ' LEU . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.827 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 6' ' ' THR . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.912 HG22 HD13 ' A' ' 7' ' ' LEU . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.658 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.49 HG22 ' OD1' ' A' ' 48' ' ' ASP . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 53' ' ' SER . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.031 ' O ' HG23 ' A' ' 61' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 57' ' ' LEU . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.205 1.002 . . . . 0.0 111.351 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.63 ' CA ' HG23 ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.9 HG23 HG22 ' A' ' 44' ' ' VAL . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.873 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.723 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 13' ' ' THR . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HB3' HG11 ' A' ' 9' ' ' VAL . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 HG13 ' A' ' 9' ' ' VAL . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.609 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.886 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.667 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.057 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' C ' ' A' ' 25' ' ' LEU . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.9 HG22 HG23 ' A' ' 6' ' ' THR . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 34' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' CA ' ' A' ' 4' ' ' THR . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.878 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 51' ' ' LYS . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' A' ' 50' ' ' THR . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.878 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.057 ' HA ' HG11 ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.866 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.632 HG22 ' HB1' ' A' ' 24' ' ' ALA . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.28 0.562 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.619 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -51.49 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.641 ' HB3' ' CD2' ' A' ' 47' ' ' PHE . 3.5 tm0? -127.03 89.4 2.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.082 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 4' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.872 HG23 HG22 ' A' ' 44' ' ' VAL . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.824 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.601 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG11 ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.021 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.818 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.935 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 26' ' ' SER . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.919 HG21 ' CD1' ' A' ' 25' ' ' LEU . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.872 HG22 HG23 ' A' ' 6' ' ' THR . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.619 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.054 ' O ' HG23 ' A' ' 61' ' ' THR . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.054 HG23 ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -44.03 125.14 4.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 108.92 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.46 156.09 31.52 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.081 -1.447 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.988 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.819 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 16' ' ' ALA . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.59 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.819 HG11 ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.692 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.931 HD21 HD22 ' A' ' 7' ' ' LEU . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.927 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 28' ' ' VAL . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 28' ' ' VAL . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.927 HG21 ' CA ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG22 ' CA ' ' A' ' 43' ' ' ALA . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.895 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.988 ' CG2' HD13 ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 46' ' ' THR . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.954 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' HB2' ' N ' ' A' ' 2' ' ' THR . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.539 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.954 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.969 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.881 ' N ' HD12 ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 57' ' ' LEU . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.698 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.552 ' HB ' ' CA ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 29.49 95.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.252 -0.28 . . . . 0.0 110.535 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -165.31 168.08 17.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.851 -1.54 . . . . 0.0 112.224 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.652 ' H ' HG12 ' A' ' 5' ' ' VAL . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.574 ' HE2' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 1.083 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.974 ' CD1' HG21 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.69 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.974 HG21 ' CD1' ' A' ' 25' ' ' LEU . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.584 ' CA ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 42' ' ' GLU . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 6' ' ' THR . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG11 HD13 ' A' ' 25' ' ' LEU . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.724 HG23 ' HB ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' CA ' ' HB ' ' A' ' 2' ' ' THR . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.533 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.898 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 57' ' ' LEU . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 58' ' ' THR . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.941 ' N ' HD12 ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 24' ' ' ALA . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.645 ' O ' HD23 ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 54' ' ' VAL . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -51.69 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.994 -0.441 . . . . 0.0 109.894 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -168.17 -169.2 1.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.507 -1.37 . . . . 0.0 111.224 -179.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 4' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.597 ' H ' HG12 ' A' ' 5' ' ' VAL . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.016 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 21' ' ' VAL . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.572 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.799 HG11 HG23 ' A' ' 9' ' ' VAL . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.016 ' CD2' HD22 ' A' ' 7' ' ' LEU . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.553 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.962 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CA ' ' A' ' 43' ' ' ALA . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CA ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.93 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 34' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.663 HG23 ' CA ' ' A' ' 4' ' ' THR . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.847 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' N ' ' OG1' ' A' ' 2' ' ' THR . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.517 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.962 ' CB ' HG21 ' A' ' 28' ' ' VAL . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.781 HG22 ' HB1' ' A' ' 24' ' ' ALA . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.777 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.52 ' CB ' HD23 ' A' ' 7' ' ' LEU . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.798 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 34.79 41.15 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.364 0.602 . . . . 0.0 109.657 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -168.41 -168.15 0.89 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.652 -1.28 . . . . 0.0 110.534 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 4' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.094 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 14' ' ' CYS . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.718 HG11 HG13 ' A' ' 9' ' ' VAL . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.911 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.766 HD11 ' HB1' ' A' ' 43' ' ' ALA . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.993 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CD1' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.094 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 25' ' ' LEU . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.684 HG23 ' CA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG22 ' HE2' ' A' ' 47' ' ' PHE . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.993 ' HA ' HG21 ' A' ' 28' ' ' VAL . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.904 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.911 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' HG22 ' A' ' 58' ' ' THR . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.656 HG22 ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -43.21 126.02 3.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.39 161.57 18.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.771 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 44' ' ' VAL . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.834 HD13 HG22 ' A' ' 45' ' ' VAL . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.92 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.538 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.785 HD12 ' HD2' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.519 ' HG1' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 HG13 ' A' ' 9' ' ' VAL . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.607 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.953 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.798 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' VAL . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG21 ' CA ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG21 ' CD1' ' A' ' 25' ' ' LEU . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.785 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 6' ' ' THR . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HD13 ' A' ' 7' ' ' LEU . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 46' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 57' ' ' LEU . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.656 ' OD2' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.604 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.028 ' HA ' HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.881 HG22 ' OG ' ' A' ' 68' ' ' SER . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.764 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.724 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.881 ' OG ' HG22 ' A' ' 58' ' ' THR . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.651 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.563 ' HA ' ' N ' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -41.26 122.38 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.79 . . . . 0.0 109.341 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 154.12 16.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 117.757 -1.577 . . . . 0.0 112.014 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 4' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.948 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.948 HD12 ' HB1' ' A' ' 16' ' ' ALA . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.762 HG11 HG13 ' A' ' 9' ' ' VAL . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.588 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' CB ' HG22 ' A' ' 61' ' ' THR . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 43' ' ' ALA . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.028 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 6' ' ' THR . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.616 HG23 ' HB ' ' A' ' 4' ' ' THR . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.83 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' N ' ' HA ' ' A' ' 2' ' ' THR . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.83 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.784 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' LEU . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 49' ' ' ASP . 8.0 t 38.43 31.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -168.11 -168.62 0.98 Allowed 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.659 -178.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.825 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.805 HD22 HD22 ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.967 HG23 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.561 ' C ' HG22 ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 9' ' ' VAL . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 61' ' ' THR . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 68' ' ' SER . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.57 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 1.054 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.471 ' C ' ' HG3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 45' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.892 HG21 ' CD1' ' A' ' 25' ' ' LEU . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 25' ' ' LEU . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 46' ' ' THR . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CE1' HD23 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 70' ' ' VAL . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.78 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.964 HG22 ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 57' ' ' LEU . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.797 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.786 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.964 ' O ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 54' ' ' VAL . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.564 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -46.08 121.78 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.013 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 11.7 pt20 -161.17 153.64 20.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.072 -1.451 . . . . 0.0 111.459 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.107 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.522 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.583 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.896 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.025 ' CD1' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.885 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.918 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.847 HG21 ' O ' ' A' ' 26' ' ' SER . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.885 HG21 ' CA ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' CD1' ' A' ' 25' ' ' LEU . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CD ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 46' ' ' THR . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' N ' ' A' ' 2' ' ' THR . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.545 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HA ' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.918 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.906 ' N ' HD12 ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.896 HG22 ' HB1' ' A' ' 24' ' ' ALA . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.452 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.587 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 1.5 t -65.83 170.16 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.666 ' CD ' HG22 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -129.49 112.21 13.54 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.556 -1.34 . . . . 0.0 109.682 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 44' ' ' VAL . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.965 HD13 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.787 ' HB3' HG11 ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.708 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 9' ' ' VAL . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 1.115 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 45' ' ' VAL . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.115 HG23 ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.973 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 26' ' ' SER . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.684 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.045 HG22 HG23 ' A' ' 6' ' ' THR . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.965 HG22 HD13 ' A' ' 7' ' ' LEU . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.785 ' OD1' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.086 ' O ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.479 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.086 HG23 ' O ' ' A' ' 57' ' ' LEU . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.577 ' OG ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.647 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.577 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.569 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -41.7 127.94 3.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.412 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -159.26 153.74 24.14 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.118 -1.433 . . . . 0.0 111.85 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD22 ' A' ' 25' ' ' LEU . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB2' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.501 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 13' ' ' THR . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.783 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 9' ' ' VAL . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 28' ' ' VAL . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 25' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 1.001 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 34' ' ' VAL . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.599 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 33' ' ' LYS . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' HB ' ' A' ' 4' ' ' THR . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' ' N ' ' A' ' 2' ' ' THR . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.552 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 58' ' ' THR . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.781 ' O ' HG23 ' A' ' 61' ' ' THR . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 57' ' ' LEU . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.852 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.852 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.761 ' CD ' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.584 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.647 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 5.0 t 45.27 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.878 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -130.12 89.18 2.76 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.303 -1.498 . . . . 0.0 109.023 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 4' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.003 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 45' ' ' VAL . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.878 ' HB3' HG12 ' A' ' 9' ' ' VAL . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.604 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.89 HD13 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 1.03 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG21 HD13 ' A' ' 25' ' ' LEU . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.832 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 6' ' ' THR . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.031 HG22 HD13 ' A' ' 7' ' ' LEU . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.753 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.775 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.599 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -46.78 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.591 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -119.84 89.64 3.17 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 120.767 -1.208 . . . . 0.0 108.743 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.009 HG23 HG22 ' A' ' 44' ' ' VAL . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.912 HD13 HG22 ' A' ' 45' ' ' VAL . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' GLY . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.679 ' C ' HG22 ' A' ' 13' ' ' THR . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.679 HG22 ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 16' ' ' ALA . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.595 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.669 HG11 HG13 ' A' ' 9' ' ' VAL . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.805 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.98 HG11 ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 26' ' ' SER . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG21 HD13 ' A' ' 25' ' ' LEU . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.827 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 6' ' ' THR . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.912 HG22 HD13 ' A' ' 7' ' ' LEU . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.658 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.49 HG22 ' OD1' ' A' ' 48' ' ' ASP . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 53' ' ' SER . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.031 ' O ' HG23 ' A' ' 61' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 57' ' ' LEU . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.557 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 1.3 t -38.13 109.06 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.663 -0.648 . . . . 0.0 109.665 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -165.34 149.95 8.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.351 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.63 ' CA ' HG23 ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.9 HG23 HG22 ' A' ' 44' ' ' VAL . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.873 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.723 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 13' ' ' THR . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HB3' HG11 ' A' ' 9' ' ' VAL . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 HG13 ' A' ' 9' ' ' VAL . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.609 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.886 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.667 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.057 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' C ' ' A' ' 25' ' ' LEU . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.9 HG22 HG23 ' A' ' 6' ' ' THR . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 34' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' CA ' ' A' ' 4' ' ' THR . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.878 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.538 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HB2' ' N ' ' A' ' 2' ' ' THR . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 51' ' ' LYS . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' A' ' 50' ' ' THR . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.878 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.057 ' HA ' HG11 ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.866 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.632 HG22 ' HB1' ' A' ' 24' ' ' ALA . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.641 ' HB3' ' CD2' ' A' ' 47' ' ' PHE . 3.5 tm0? . . . . . 0 C--O 1.212 -0.885 0 CA-C-O 121.643 0.735 . . . . 0.0 109.082 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 4' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.872 HG23 HG22 ' A' ' 44' ' ' VAL . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.824 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.601 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG11 ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 1.021 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.818 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.935 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 26' ' ' SER . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.919 HG21 ' CD1' ' A' ' 25' ' ' LEU . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.872 HG22 HG23 ' A' ' 6' ' ' THR . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.606 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.054 ' O ' HG23 ' A' ' 61' ' ' THR . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.054 HG23 ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.243 1.02 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.988 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.819 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 16' ' ' ALA . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.59 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.819 HG11 ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.692 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.931 HD21 HD22 ' A' ' 7' ' ' LEU . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.927 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 28' ' ' VAL . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 28' ' ' VAL . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.927 HG21 ' CA ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG22 ' CA ' ' A' ' 43' ' ' ALA . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.895 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.988 ' CG2' HD13 ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 46' ' ' THR . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.954 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.954 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.969 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.881 ' N ' HD12 ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 57' ' ' LEU . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.698 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 122.537 1.161 . . . . 0.0 112.224 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.652 ' H ' HG12 ' A' ' 5' ' ' VAL . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.574 ' HE2' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 1.083 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.974 ' CD1' HG21 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.69 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.974 HG21 ' CD1' ' A' ' 25' ' ' LEU . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.584 ' CA ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 42' ' ' GLU . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 6' ' ' THR . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.726 HG11 HD13 ' A' ' 25' ' ' LEU . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.724 HG23 ' HB ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.533 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.898 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 57' ' ' LEU . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 58' ' ' THR . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.941 ' N ' HD12 ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 24' ' ' ALA . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.645 ' O ' HD23 ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 54' ' ' VAL . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 122.385 1.088 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 4' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.597 ' H ' HG12 ' A' ' 5' ' ' VAL . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.016 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 21' ' ' VAL . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.572 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.799 HG11 HG23 ' A' ' 9' ' ' VAL . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.016 ' CD2' HD22 ' A' ' 7' ' ' LEU . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.553 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.962 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CA ' ' A' ' 43' ' ' ALA . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CA ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.93 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 34' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.663 HG23 ' CA ' ' A' ' 4' ' ' THR . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.847 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.517 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.962 ' CB ' HG21 ' A' ' 28' ' ' VAL . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.781 HG22 ' HB1' ' A' ' 24' ' ' ALA . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.777 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.52 ' CB ' HD23 ' A' ' 7' ' ' LEU . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.798 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 122.268 1.033 . . . . 0.0 110.534 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 4' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.094 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 14' ' ' CYS . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.565 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.718 HG11 HG13 ' A' ' 9' ' ' VAL . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.911 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.766 HD11 ' HB1' ' A' ' 43' ' ' ALA . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.993 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CD1' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.094 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 25' ' ' LEU . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.684 HG23 ' CA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.568 HG22 ' HE2' ' A' ' 47' ' ' PHE . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.993 ' HA ' HG21 ' A' ' 28' ' ' VAL . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.904 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.911 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.459 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' HG22 ' A' ' 58' ' ' THR . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 122.134 0.968 . . . . 0.0 110.771 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 44' ' ' VAL . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.834 HD13 HG22 ' A' ' 45' ' ' VAL . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.92 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.538 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.785 HD12 ' HD2' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.519 ' HG1' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 HG13 ' A' ' 9' ' ' VAL . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.607 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.953 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.798 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' VAL . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.798 HG21 ' CA ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG21 ' CD1' ' A' ' 25' ' ' LEU . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.785 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 6' ' ' THR . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HD13 ' A' ' 7' ' ' LEU . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 46' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 57' ' ' LEU . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 49' ' ' ASP . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.604 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.028 ' HA ' HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.881 HG22 ' OG ' ' A' ' 68' ' ' SER . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.764 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.724 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.881 ' OG ' HG22 ' A' ' 58' ' ' THR . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.651 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 122.531 1.158 . . . . 0.0 112.014 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 4' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.948 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.948 HD12 ' HB1' ' A' ' 16' ' ' ALA . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.762 HG11 HG13 ' A' ' 9' ' ' VAL . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.588 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' CB ' HG22 ' A' ' 61' ' ' THR . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 43' ' ' ALA . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.028 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 6' ' ' THR . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.616 HG23 ' HB ' ' A' ' 4' ' ' THR . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.83 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.83 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.784 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' LEU . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 122.164 0.983 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.825 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.805 HD22 HD22 ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.967 HG23 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.561 ' C ' HG22 ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 9' ' ' VAL . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 61' ' ' THR . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 68' ' ' SER . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.57 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 1.054 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.471 ' C ' ' HG3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 45' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.892 HG21 ' CD1' ' A' ' 25' ' ' LEU . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 25' ' ' LEU . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 46' ' ' THR . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CE1' HD23 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 70' ' ' VAL . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.78 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.964 HG22 ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 57' ' ' LEU . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.797 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.786 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.964 ' O ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 54' ' ' VAL . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 20.4 pt20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 122.306 1.05 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.107 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.522 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.583 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.896 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.025 ' CD1' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.885 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.918 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.847 HG21 ' O ' ' A' ' 26' ' ' SER . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.885 HG21 ' CA ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' CD1' ' A' ' 25' ' ' LEU . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CD ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 46' ' ' THR . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 52' ' ' ALA . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.545 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HA ' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.918 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.906 ' N ' HD12 ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.896 HG22 ' HB1' ' A' ' 24' ' ' ALA . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.452 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.666 ' CD ' HG22 ' A' ' 54' ' ' VAL . 1.8 mp0 . . . . . 0 C--O 1.21 -0.983 0 CA-C-O 121.807 0.813 . . . . 0.0 109.682 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 44' ' ' VAL . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.965 HD13 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.787 ' HB3' HG11 ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.708 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 9' ' ' VAL . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 1.115 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 45' ' ' VAL . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.115 HG23 ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.973 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 26' ' ' SER . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.684 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.045 HG22 HG23 ' A' ' 6' ' ' THR . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.965 HG22 HD13 ' A' ' 7' ' ' LEU . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.785 ' OD1' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.086 ' O ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.479 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.086 HG23 ' O ' ' A' ' 57' ' ' LEU . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.577 ' OG ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.647 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 47' ' ' PHE . 3.8 mt-30 . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 122.341 1.067 . . . . 0.0 111.85 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD22 ' A' ' 25' ' ' LEU . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB2' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.501 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 13' ' ' THR . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.783 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 9' ' ' VAL . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 28' ' ' VAL . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 25' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 1.001 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 34' ' ' VAL . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.599 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 33' ' ' LYS . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' HB ' ' A' ' 4' ' ' THR . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.552 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 58' ' ' THR . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.781 ' O ' HG23 ' A' ' 61' ' ' THR . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 57' ' ' LEU . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.852 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.852 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.761 ' CD ' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 121.768 0.794 . . . . 0.0 109.023 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 4' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.003 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 45' ' ' VAL . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.878 ' HB3' HG12 ' A' ' 9' ' ' VAL . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.604 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.89 HD13 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 1.03 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.89 HG21 HD13 ' A' ' 25' ' ' LEU . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.832 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 6' ' ' THR . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.031 HG22 HD13 ' A' ' 7' ' ' LEU . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.605 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.753 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.775 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.21 -0.997 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.009 HG23 HG22 ' A' ' 44' ' ' VAL . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.912 HD13 HG22 ' A' ' 45' ' ' VAL . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' GLY . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.679 ' C ' HG22 ' A' ' 13' ' ' THR . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.679 HG22 ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 16' ' ' ALA . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.595 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.669 HG11 HG13 ' A' ' 9' ' ' VAL . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.66 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.805 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.98 HG11 ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 26' ' ' SER . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.895 HG21 HD13 ' A' ' 25' ' ' LEU . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.827 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 6' ' ' THR . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.912 HG22 HD13 ' A' ' 7' ' ' LEU . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.658 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.49 HG22 ' OD1' ' A' ' 48' ' ' ASP . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 53' ' ' SER . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.031 ' O ' HG23 ' A' ' 61' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 57' ' ' LEU . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 122.205 1.002 . . . . 0.0 111.351 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.63 ' CA ' HG23 ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.9 HG23 HG22 ' A' ' 44' ' ' VAL . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.873 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.723 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 13' ' ' THR . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HB3' HG11 ' A' ' 9' ' ' VAL . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.467 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 HG13 ' A' ' 9' ' ' VAL . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.609 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.886 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.667 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.057 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' C ' ' A' ' 25' ' ' LEU . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.9 HG22 HG23 ' A' ' 6' ' ' THR . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 34' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' CA ' ' A' ' 4' ' ' THR . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.878 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 51' ' ' LYS . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' A' ' 50' ' ' THR . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.878 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.057 ' HA ' HG11 ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.866 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.632 HG22 ' HB1' ' A' ' 24' ' ' ALA . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.28 0.562 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.619 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -51.49 175.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 109.527 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.641 ' HB3' ' CD2' ' A' ' 47' ' ' PHE . 3.5 tm0? -127.03 89.4 2.97 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.082 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.799 ' O ' HG23 ' A' ' 4' ' ' THR . 11.7 t -121.46 83.85 2.15 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -161.67 -167.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.046 -1.034 . . . . 0.0 109.446 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.872 HG23 HG22 ' A' ' 44' ' ' VAL . 22.2 m -86.36 147.64 25.95 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.74 HD22 HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -130.64 136.96 49.35 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 108.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -83.32 138.62 33.47 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.824 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -125.66 111.56 25.3 Favored Pre-proline 0 C--N 1.297 -1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 -178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.3 Cg_exo -56.64 -162.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.056 1.556 . . . . 0.0 110.443 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 84.9 -60.59 4.79 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.534 ' N ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 36.81 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.849 -0.795 . . . . 0.0 111.071 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.2 t -82.43 13.24 3.75 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.664 -0.647 . . . . 0.0 110.516 -178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.7 t -70.21 143.84 52.08 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.912 -1.117 . . . . 0.0 109.076 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -42.12 -27.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.311 -0.868 . . . . 0.0 109.734 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 167.04 39.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.188 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 59.8 m -75.14 -46.06 4.69 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.248 -0.907 . . . . 0.0 109.615 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.6 Cg_endo -62.23 -29.8 80.81 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.652 1.343 . . . . 0.0 110.292 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.601 HG12 ' CG ' ' A' ' 38' ' ' PHE . 4.9 mm -48.56 -27.57 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.593 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.33 -41.02 11.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.471 -0.768 . . . . 0.0 109.47 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG11 ' HB ' ' A' ' 9' ' ' VAL . 76.7 t -44.41 -46.72 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.2 -0.938 . . . . 0.0 108.494 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -47.24 -68.47 0.19 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.872 -1.142 . . . . 0.0 109.53 179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 27' ' ' LYS . 8.6 mttt -51.88 -45.01 63.96 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.021 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -40.18 -49.0 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.804 -0.56 . . . . 0.0 109.984 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.919 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.8 mt -63.69 -63.48 1.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.773 -1.205 . . . . 0.0 109.243 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.818 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.8 t -72.67 8.85 1.28 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 111.266 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -107.26 -29.09 9.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.379 -1.451 . . . . 0.0 109.378 179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.021 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.6 t -77.53 -159.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.969 -1.082 . . . . 0.0 108.735 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.935 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 3.2 mp0 -87.85 161.31 17.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.0 109.913 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.44 -10.14 68.0 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 26' ' ' SER . 17.6 t -41.11 159.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.303 -1.116 . . . . 0.0 109.451 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -168.15 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.93 172.16 13.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 45' ' ' VAL . 10.9 p -159.84 146.69 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 117.75 -1.58 . . . . 0.0 112.046 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.1 m-20 -164.82 86.74 0.44 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.919 HG21 ' CD1' ' A' ' 25' ' ' LEU . 96.7 t -144.48 156.17 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 0.0 109.395 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.23 159.34 32.66 Favored Glycine 0 N--CA 1.48 1.595 0 C-N-CA 118.376 -1.868 . . . . 0.0 111.59 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' CG ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.42 -15.76 24.0 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.407 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.9 mp0 -39.23 -30.64 0.06 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 3.3 mmtm -137.1 -82.59 0.36 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB3' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 169.6 61.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 23.8 mm-40 -136.62 133.64 36.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.806 -1.184 . . . . 0.0 109.981 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -123.08 89.22 3.07 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.296 -0.878 . . . . 0.0 110.146 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.872 HG22 HG23 ' A' ' 6' ' ' THR . 94.9 t -97.21 127.62 49.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 34' ' ' VAL . 16.1 m -157.96 166.88 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 120.659 -1.276 . . . . 0.0 110.243 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.5 m -132.78 95.04 3.5 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 57' ' ' LEU . 13.4 p90 -115.71 -173.15 2.29 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.619 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 1.8 p-10 -162.36 155.15 19.75 Favored 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 116.604 -2.038 . . . . 0.0 111.569 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 12.4 m-20 -74.39 3.7 7.05 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.871 -0.518 . . . . 0.0 110.986 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.2 m -45.04 -29.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.969 -1.082 . . . . 0.0 108.29 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.86 13.67 0.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.607 -0.683 . . . . 0.0 109.51 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -154.48 -154.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.857 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -162.18 166.5 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.545 -0.722 . . . . 0.0 109.064 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 4.7 t -66.02 -53.2 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.896 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.3 tt0 -57.03 -39.3 74.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.148 -0.97 . . . . 0.0 108.757 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.43 -58.21 8.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.288 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.054 ' O ' HG23 ' A' ' 61' ' ' THR . 0.6 OUTLIER -56.56 -65.01 0.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.206 -0.934 . . . . 0.0 109.09 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 p -51.86 -43.94 63.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.727 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 10.8 tttm -55.55 -53.09 60.73 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.987 -1.071 . . . . 0.0 108.906 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.35 -29.37 69.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.32 -0.862 . . . . 0.0 108.837 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.054 HG23 ' O ' ' A' ' 57' ' ' LEU . 17.4 p -73.16 -50.81 20.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.415 -0.803 . . . . 0.0 109.136 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.725 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -66.18 -11.22 48.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.16 0.15 57.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.928 . . . . 0.0 109.952 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.07 9.92 11.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.035 -1.041 . . . . 0.0 109.74 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 96.42 -33.31 5.74 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.612 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -111.08 109.87 56.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.725 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 5.9 Cg_exo -103.25 -155.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.675 1.355 . . . . 0.0 111.93 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.83 -173.23 4.37 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.63 0.729 . . . . 0.0 109.726 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -166.34 161.32 16.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 21.4 t -84.6 149.08 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.976 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -159.0 159.17 34.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.101 -0.999 . . . . 0.0 109.377 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.552 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -44.03 125.14 4.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 108.92 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -157.46 156.09 31.52 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.081 -1.447 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.741 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -125.81 104.64 8.44 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' THR . 19.9 m -160.48 -167.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.847 -1.158 . . . . 0.0 110.013 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 71' ' ' LYS . 97.5 m -85.3 148.15 26.19 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.988 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -128.57 137.0 51.5 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 108.797 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -83.35 134.54 34.9 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.174 -0.953 . . . . 0.0 108.557 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.819 ' HB ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -122.35 108.12 34.09 Favored Pre-proline 0 C--N 1.299 -1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.221 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.0 Cg_exo -54.71 -164.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.14 1.6 . . . . 0.0 110.235 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 94.6 -63.69 1.59 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.548 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 39.9 mtm 49.28 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.552 -0.97 . . . . 0.0 110.232 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -103.21 -0.82 29.89 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.587 -0.696 . . . . 0.0 109.845 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.511 ' O ' ' N ' ' A' ' 16' ' ' ALA . 12.5 t -43.88 166.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.329 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -67.87 60.08 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.313 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.632 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . 70.02 42.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 99.6 m -82.67 -45.75 0.91 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.608 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.8 Cg_endo -62.09 -26.99 78.6 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.626 1.33 . . . . 0.0 109.93 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.632 HD12 ' HB1' ' A' ' 16' ' ' ALA . 9.9 mt -51.33 -29.45 9.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.59 ' HB ' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.05 -39.39 14.67 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.819 HG11 ' HB ' ' A' ' 9' ' ' VAL . 50.1 t -45.29 -50.66 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.569 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 5.0 tttp -43.94 -62.16 1.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.143 -0.973 . . . . 0.0 109.302 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -58.04 -31.85 67.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.692 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.98 -51.74 49.69 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.284 -0.885 . . . . 0.0 109.219 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.931 HD21 HD22 ' A' ' 7' ' ' LEU . 3.7 mt -65.25 -73.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.927 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -45.69 -20.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.804 -0.56 . . . . 0.0 111.235 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -98.35 -1.86 40.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.326 -1.484 . . . . 0.0 109.197 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.969 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -90.72 -171.73 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' N ' HG13 ' A' ' 28' ' ' VAL . 68.9 mm-40 -85.23 155.46 21.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.15 -0.969 . . . . 0.0 110.408 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 75.98 -3.25 52.27 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 28' ' ' VAL . 33.0 t -46.43 89.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.546 -0.973 . . . . 0.0 109.99 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -84.63 -42.68 15.13 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.747 -1.221 . . . . 0.0 108.421 179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 46' ' ' THR . 2.2 tttt -154.53 158.78 40.35 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.927 HG21 ' CA ' ' A' ' 26' ' ' SER . 24.3 t -150.05 134.02 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.286 -1.366 . . . . 0.0 111.89 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.22 88.26 2.15 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 177.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG22 ' CA ' ' A' ' 43' ' ' ALA . 92.5 t -136.66 158.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.398 -0.814 . . . . 0.0 110.364 -177.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.93 157.2 29.56 Favored Glycine 0 N--CA 1.481 1.646 0 C-N-CA 118.732 -1.699 . . . . 0.0 111.466 178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -94.83 -12.66 26.57 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 38' ' ' PHE . 20.9 mm-40 -40.78 -30.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 43.7 mtpt -138.69 -83.43 0.29 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 4.2 ptp180 171.2 62.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' C ' ' CG1' ' A' ' 9' ' ' VAL . 16.9 mt-10 -140.66 134.74 30.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.639 -1.288 . . . . 0.0 110.032 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.895 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -128.58 88.75 2.78 Favored 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.268 -0.895 . . . . 0.0 110.493 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 67.9 t -85.01 124.01 39.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.988 ' CG2' HD13 ' A' ' 7' ' ' LEU . 23.7 m -158.68 161.33 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 120.471 -1.393 . . . . 0.0 110.041 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 46' ' ' THR . 4.9 t -129.49 103.42 6.88 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.323 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.954 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 28.3 p90 -98.7 115.37 28.57 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.8 OUTLIER -95.61 51.1 1.26 Allowed 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 118.131 -1.427 . . . . 0.0 110.85 -177.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' HB2' ' N ' ' A' ' 2' ' ' THR . 51.3 t0 33.6 30.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.362 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.539 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 37.9 m -58.1 -17.5 18.62 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 108.24 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 29' ' ' GLU . 3.2 mttm -168.44 17.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.313 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.71 -158.01 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.65 -1.281 . . . . 0.0 109.997 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -151.82 -178.89 7.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.872 . . . . 0.0 109.571 -179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.954 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 3.8 t -59.18 -60.98 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.604 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -56.6 -33.02 65.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.165 -0.96 . . . . 0.0 109.488 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.7 -54.92 7.69 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.195 -0.94 . . . . 0.0 109.235 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.969 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.5 pp -63.47 -50.96 67.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.092 -1.005 . . . . 0.0 109.187 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.881 ' N ' HD12 ' A' ' 57' ' ' LEU . 24.2 p -53.76 -50.97 64.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 4.3 mmtp -46.6 -52.28 13.89 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.265 -0.897 . . . . 0.0 109.352 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.15 85.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.312 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 57' ' ' LEU . 6.6 p -63.75 -49.8 71.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.0 109.396 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.698 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -62.61 -15.07 49.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.155 -0.966 . . . . 0.0 109.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.2 0.79 50.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.984 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.1 9.66 13.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.089 -1.007 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.24 -33.43 5.44 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.683 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -110.8 111.73 56.48 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.698 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 6.1 Cg_exo -105.87 -155.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.582 1.306 . . . . 0.0 111.849 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.475 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -163.46 -177.11 5.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.645 -0.659 . . . . 0.0 109.36 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.623 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 1.1 m -165.29 165.26 19.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.428 -0.795 . . . . 0.0 109.2 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.7 p -84.39 152.42 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.201 -0.937 . . . . 0.0 110.004 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -151.51 125.03 8.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.248 -0.908 . . . . 0.0 109.247 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.1 tp60 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.475 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.552 ' HB ' ' CA ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 29.49 95.3 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.252 -0.28 . . . . 0.0 110.535 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -165.31 168.08 17.23 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 117.851 -1.54 . . . . 0.0 112.224 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -113.56 103.02 10.84 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.652 HG12 ' H ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -157.19 -166.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.639 -1.288 . . . . 0.0 109.961 -177.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.652 ' H ' HG12 ' A' ' 5' ' ' VAL . 60.9 m -94.25 147.5 23.13 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.243 -0.911 . . . . 0.0 108.659 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -134.34 138.28 44.79 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.89 131.81 54.66 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 120.668 -1.27 . . . . 0.0 109.187 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 ' HB3' ' A' ' 18' ' ' PRO . 2.8 m -84.39 -175.76 0.68 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.126 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 12' ' ' MET . 2.7 Cg_endo -114.88 -9.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.529 1.278 . . . . 0.0 110.946 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -57.69 -53.55 44.31 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.574 ' HE2' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 50.67 100.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.632 -0.923 . . . . 0.0 109.272 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 6.0 t 38.96 45.02 0.93 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.189 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 42.0 t -89.06 23.4 2.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.628 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 81.88 -46.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.574 -0.704 . . . . 0.0 109.486 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' HA ' HG13 ' A' ' 19' ' ' ILE . . . -177.93 29.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.028 . . . . 0.0 110.404 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 4.6 m -87.85 -42.27 0.5 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 120.786 -1.196 . . . . 0.0 109.277 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 1.083 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.1 Cg_exo -72.84 -25.41 16.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.474 1.249 . . . . 0.0 109.422 178.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.56 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 14.4 mt -49.72 -24.67 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -89.98 -42.99 10.85 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.749 -0.595 . . . . 0.0 109.47 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 9' ' ' VAL . 92.1 t -45.68 -46.24 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 3.7 ttpt -45.7 -67.16 0.31 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.88 . . . . 0.0 109.287 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -55.41 -35.5 65.44 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.899 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -50.38 -47.37 56.26 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.332 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.974 ' CD1' HG21 ' A' ' 36' ' ' VAL . 1.3 mt -65.44 -70.27 0.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.058 -1.026 . . . . 0.0 108.662 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.69 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.03 -12.28 1.4 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.549 -0.72 . . . . 0.0 110.885 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.17 -1.23 27.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.357 -1.464 . . . . 0.0 109.498 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.829 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -89.97 -165.39 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 108.82 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.898 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 1.8 mp0 -90.82 147.8 22.95 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 109.429 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 90.13 -13.9 63.63 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.69 HG21 ' O ' ' A' ' 26' ' ' SER . 68.1 t -30.96 148.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.964 -0.727 . . . . 0.0 110.676 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -163.47 -50.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' CB ' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -131.75 143.36 50.18 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.3 p -139.2 106.21 2.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.049 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -129.72 87.07 2.48 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 176.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.974 HG21 ' CD1' ' A' ' 25' ' ' LEU . 79.3 t -141.58 155.25 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -0.837 . . . . 0.0 110.301 -176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.65 161.2 34.99 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.579 -1.772 . . . . 0.0 111.662 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -84.13 -16.29 44.11 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 17.6 mt-10 -46.54 -25.0 0.6 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.546 -0.722 . . . . 0.0 109.455 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -168.41 52.64 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 110.497 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.584 ' CA ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 31.55 42.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.748 -0.595 . . . . 0.0 111.258 179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 42' ' ' GLU . 10.9 pt-20 -108.78 126.58 53.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 0.0 108.796 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -131.34 87.71 2.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.877 -1.14 . . . . 0.0 110.796 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG22 HG23 ' A' ' 6' ' ' THR . 1.5 t -90.2 130.2 39.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.726 HG11 HD13 ' A' ' 25' ' ' LEU . 34.2 m -158.12 179.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 120.607 -1.308 . . . . 0.0 109.994 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.724 HG23 ' HB ' ' A' ' 4' ' ' THR . 68.3 m -141.93 91.56 2.36 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.079 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.641 ' CD2' ' CD2' ' A' ' 57' ' ' LEU . 1.3 p90 -100.75 118.27 36.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -98.06 172.14 7.81 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.092 -177.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' CA ' ' HB ' ' A' ' 2' ' ' THR . 16.8 p-10 -68.23 53.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 0.0 109.683 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.533 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.9 m -86.15 -16.41 37.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.194 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.56 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 165.88 29.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 111.214 -179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.898 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -175.15 -168.73 0.35 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.829 -1.169 . . . . 0.0 109.863 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.1 OUTLIER -143.6 176.53 9.14 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.445 -0.784 . . . . 0.0 108.911 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HA ' HD21 ' A' ' 57' ' ' LEU . 1.4 p -65.83 -46.55 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 109.71 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.517 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 4.0 tt0 -75.24 -22.76 57.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 108.766 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -51.82 10.15 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.433 -0.792 . . . . 0.0 109.01 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.941 HD12 ' N ' ' A' ' 58' ' ' THR . 3.5 pp -59.95 -51.06 71.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 109.008 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.941 ' N ' HD12 ' A' ' 57' ' ' LEU . 2.1 p -55.48 -46.36 76.89 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.159 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 2.8 tmtt? -45.73 -51.37 12.65 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.208 -0.932 . . . . 0.0 108.792 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.99 93.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.293 -0.88 . . . . 0.0 108.727 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.899 HG22 ' HB1' ' A' ' 24' ' ' ALA . 22.8 p -62.93 -40.9 99.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.356 -0.84 . . . . 0.0 108.89 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -70.15 -17.13 63.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.186 -0.946 . . . . 0.0 109.713 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.83 0.9 54.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.869 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.23 6.17 16.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.67 -34.65 5.29 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CB ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -114.66 110.06 47.31 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.695 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -101.52 -157.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.756 1.398 . . . . 0.0 111.555 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.602 ' HB3' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -156.93 174.94 14.75 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.663 0.744 . . . . 0.0 110.299 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.645 ' O ' HD23 ' A' ' 7' ' ' LEU . 54.1 m -151.89 172.46 16.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.528 -0.733 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 54' ' ' VAL . 3.4 m -84.28 150.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.127 -0.983 . . . . 0.0 110.069 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -145.88 119.66 9.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.058 -1.026 . . . . 0.0 109.203 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' O ' HG11 ' A' ' 5' ' ' VAL . 2.8 mm100 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.531 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' N ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -51.69 74.77 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.994 -0.441 . . . . 0.0 109.894 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.617 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -168.17 -169.2 1.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 O-C-N 120.507 -1.37 . . . . 0.0 111.224 -179.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 4' ' ' THR . 14.9 t -110.71 108.58 18.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -158.42 -167.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.786 -1.196 . . . . 0.0 109.928 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.597 ' H ' HG12 ' A' ' 5' ' ' VAL . 17.7 m -98.33 140.6 32.37 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.371 -0.831 . . . . 0.0 109.526 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.016 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -115.64 127.48 55.22 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -82.96 103.74 12.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.025 -1.047 . . . . 0.0 108.723 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 21' ' ' VAL . 12.4 p -84.87 128.93 58.54 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.444 -0.785 . . . . 0.0 110.111 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 6.9 Cg_exo -79.64 -160.75 0.13 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 124.038 1.546 . . . . 0.0 110.673 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 87.96 -61.68 4.0 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 36.46 -87.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.765 0.793 . . . . 0.0 110.614 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.593 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.5 p -57.34 -31.29 65.58 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.779 -0.576 . . . . 0.0 109.698 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.566 ' O ' ' CE1' ' A' ' 38' ' ' PHE . 1.4 t -40.95 134.51 1.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.599 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -41.83 -34.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.0 109.896 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . . . 175.7 54.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.452 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 72.9 m -84.68 -43.89 0.7 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.176 -0.952 . . . . 0.0 109.798 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.572 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 2.3 Cg_endo -66.75 -21.67 51.0 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.582 1.306 . . . . 0.0 110.176 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 1.6 tt -55.12 -34.24 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.583 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -88.32 -36.71 16.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.427 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.799 HG11 HG23 ' A' ' 9' ' ' VAL . 63.5 t -45.73 -45.4 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 72.2 tttt -43.24 -66.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.881 0.848 . . . . 0.0 109.552 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 29.3 mttt -58.92 -36.4 74.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -55.4 -39.44 70.18 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.2 -0.938 . . . . 0.0 109.319 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.016 ' CD2' HD22 ' A' ' 7' ' ' LEU . 9.3 mt -67.52 -71.49 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 108.837 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.553 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 p -56.99 -28.31 62.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -80.5 -1.59 42.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.209 -1.557 . . . . 0.0 109.129 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.962 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -89.5 -170.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.303 -0.873 . . . . 0.0 108.985 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 16.6 mm-40 -84.69 146.0 27.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.104 -0.998 . . . . 0.0 109.985 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 86.53 -14.51 55.05 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -36.94 141.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.639 -0.918 . . . . 0.0 109.807 179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -149.9 -44.13 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' N ' ' HB ' ' A' ' 46' ' ' THR . 5.2 tttm -123.77 151.05 43.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.653 ' HA ' HG12 ' A' ' 45' ' ' VAL . 4.0 p -142.83 89.06 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.643 -1.285 . . . . 0.0 111.263 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' VAL . 1.2 m-20 -124.73 87.82 2.78 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG22 ' CA ' ' A' ' 43' ' ' ALA . 91.2 t -142.98 155.95 17.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.434 -0.791 . . . . 0.0 110.065 -177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.416 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.69 160.63 34.29 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 118.801 -1.666 . . . . 0.0 111.296 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CD1' ' O ' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -96.14 -10.64 27.74 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' C ' ' O ' ' A' ' 38' ' ' PHE . 8.3 mt-10 -40.91 -29.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -138.34 -68.7 0.45 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER 153.06 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' CA ' HG12 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -135.09 143.88 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 108.832 -179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.93 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -135.86 88.35 2.39 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.475 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 35' ' ' ASP . 82.4 t -89.36 129.52 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 34' ' ' VAL . 35.0 m -159.51 -170.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 120.826 -1.171 . . . . 0.0 109.68 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.663 HG23 ' CA ' ' A' ' 4' ' ' THR . 95.8 m -147.66 92.65 2.1 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.02 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.847 ' CD2' HD21 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -104.07 112.1 24.95 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 178.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -92.01 166.88 12.46 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.633 -177.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.566 ' N ' ' OG1' ' A' ' 2' ' ' THR . 6.9 p30 -67.35 55.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.345 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.517 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 2.2 m -89.32 -17.88 28.03 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.393 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.552 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 169.95 28.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.158 -1.017 . . . . 0.0 111.317 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.796 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -177.17 -169.54 0.25 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.811 -1.18 . . . . 0.0 109.916 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -143.69 176.42 9.24 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.432 -0.793 . . . . 0.0 108.886 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.64 ' N ' ' CZ ' ' A' ' 47' ' ' PHE . 1.1 p -66.73 -48.24 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.987 -1.07 . . . . 0.0 109.529 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 41.3 mt-30 -70.43 -23.6 62.76 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -56.77 4.1 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.441 -0.787 . . . . 0.0 108.985 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.962 ' CB ' HG21 ' A' ' 28' ' ' VAL . 1.3 pp -61.47 -49.07 78.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.973 -1.079 . . . . 0.0 109.243 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 54' ' ' VAL . 24.2 p -50.19 -53.21 29.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 109.013 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' THR . 0.4 OUTLIER -44.54 -57.49 3.57 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.043 -179.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.69 -39.36 36.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.781 HG22 ' HB1' ' A' ' 24' ' ' ALA . 4.1 p -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.777 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.8 -27.63 69.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.87 -23.25 67.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.885 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.96 25.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.151 -0.968 . . . . 0.0 109.666 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 89.42 -27.05 8.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -109.99 113.04 57.46 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.453 -1.028 . . . . 0.0 108.823 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.777 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.9 Cg_endo -114.32 -158.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 116.741 -1.706 . . . . 0.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.52 ' CB ' HD23 ' A' ' 7' ' ' LEU . 1.7 t -153.54 177.58 10.77 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.773 0.797 . . . . 0.0 110.055 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 98.8 p -149.74 162.48 40.18 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -82.96 152.24 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 110.073 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.798 ' HG3' ' HB2' ' A' ' 8' ' ' ALA . 1.4 mmtt -152.17 128.18 10.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.387 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.508 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER 34.79 41.15 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.364 0.602 . . . . 0.0 109.657 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -168.41 -168.15 0.89 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.652 -1.28 . . . . 0.0 110.534 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 4' ' ' THR . 14.4 t -89.2 111.95 22.86 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 4' ' ' THR . 35.8 m -159.28 -167.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.958 -1.089 . . . . 0.0 110.048 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 7' ' ' LEU . 8.7 m -102.08 169.05 8.99 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.337 -0.852 . . . . 0.0 109.445 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.765 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -160.09 139.14 10.76 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -86.4 153.45 21.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -0.958 . . . . 0.0 109.435 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.094 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 10.6 t -123.01 108.63 32.34 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.992 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 5.0 Cg_exo -56.9 171.25 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.89 0 O-C-N 124.097 1.578 . . . . 0.0 109.735 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 90.7 -64.41 2.81 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.201 -1.959 . . . . 0.0 108.201 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 60.41 -73.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.833 -0.804 . . . . 0.0 110.425 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 14' ' ' CYS . 24.1 p -80.08 -97.04 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.689 -0.632 . . . . 0.0 109.518 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.565 ' N ' ' OG1' ' A' ' 13' ' ' THR . 3.9 t 50.56 177.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.216 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 16' ' ' ALA . . . -89.13 -6.41 57.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.957 -1.089 . . . . 0.0 109.182 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 159.73 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.569 ' SG ' ' CE1' ' A' ' 66' ' ' TYR . 7.5 m -70.25 -66.67 0.79 Allowed Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 121.493 -0.754 . . . . 0.0 109.578 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.656 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -58.44 -28.05 83.92 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.496 1.261 . . . . 0.0 110.672 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.647 HG21 ' HB1' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -46.19 -37.53 2.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -82.51 -42.12 18.82 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.656 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.718 HG11 HG13 ' A' ' 9' ' ' VAL . 54.3 t -46.56 -47.2 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.103 -0.998 . . . . 0.0 109.031 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -42.85 -64.28 0.65 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.792 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.6 mttt -55.52 -39.9 71.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.911 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -49.3 -47.03 47.28 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.57 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.766 HD11 ' HB1' ' A' ' 43' ' ' ALA . 34.8 mt -61.93 -70.45 0.19 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 108.936 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -62.0 -6.32 2.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.695 -0.628 . . . . 0.0 111.338 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -107.79 -10.66 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.319 -1.488 . . . . 0.0 109.81 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.993 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -82.61 -164.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.23 -0.919 . . . . 0.0 109.076 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.877 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 10.9 mt-10 -88.76 148.1 24.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.08 -1.013 . . . . 0.0 109.672 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 91.85 -16.19 59.96 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 28' ' ' VAL . 56.1 t -31.9 149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 122.02 -0.694 . . . . 0.0 110.294 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -164.57 -41.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' HG3' ' CB ' ' A' ' 46' ' ' THR . 4.8 mttm -136.55 171.33 14.64 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.778 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.24 101.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.423 -1.423 . . . . 0.0 112.011 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 44' ' ' VAL . 3.8 m-20 -130.68 85.84 2.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 177.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -156.08 154.01 6.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.199 -0.938 . . . . 0.0 110.113 -177.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -166.7 166.07 38.81 Favored Glycine 0 N--CA 1.486 1.988 0 C-N-CA 118.981 -1.581 . . . . 0.0 111.359 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CD1' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.01 -9.93 29.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -42.55 -28.77 0.24 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 7.5 mtpp -138.82 -84.37 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 172.83 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 36' ' ' VAL . 65.8 mt-10 -131.48 129.97 41.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.635 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.094 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.44 88.08 2.82 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.294 -0.879 . . . . 0.0 110.567 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -100.31 124.64 53.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 25' ' ' LEU . 7.5 m -159.98 -178.05 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.41 -1.431 . . . . 0.0 109.612 -177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.684 HG23 ' CA ' ' A' ' 4' ' ' THR . 58.1 m -137.97 95.53 3.05 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.53 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.661 ' CE2' HD21 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -112.21 110.32 20.51 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -89.58 163.12 15.31 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.239 -0.984 . . . . 0.0 109.384 -177.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.2 p30 -67.11 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.925 -1.11 . . . . 0.0 109.559 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.1 m -86.17 -20.89 27.92 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.542 -0.724 . . . . 0.0 109.112 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER 178.04 25.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.216 -0.927 . . . . 0.0 111.234 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -171.87 -167.73 0.52 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.83 -1.169 . . . . 0.0 109.902 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.555 ' C ' ' CZ ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -147.46 -178.53 6.29 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.568 HG22 ' HE2' ' A' ' 47' ' ' PHE . 2.1 t -66.08 -56.2 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 109.4 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -61.68 -30.47 70.76 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.269 -0.895 . . . . 0.0 109.033 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -58.41 3.93 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.993 ' HA ' HG21 ' A' ' 28' ' ' VAL . 3.6 pp -59.75 -51.52 69.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.093 -1.004 . . . . 0.0 109.499 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.904 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.9 p -56.33 -48.36 76.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.048 -1.033 . . . . 0.0 109.364 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 47.4 tptt -49.17 -55.55 12.07 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 109.414 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.93 -58.43 6.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.133 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.911 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 9.4 t -59.49 -39.0 82.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.153 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -59.64 -17.42 33.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.368 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -77.04 -2.77 35.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 109.863 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -114.17 12.9 17.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.749 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.459 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 84.35 -11.32 58.72 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -122.29 99.74 42.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.312 -1.111 . . . . 0.0 108.898 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.73 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.1 Cg_endo -112.38 -157.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.571 1.301 . . . . 0.0 111.043 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HB3' HG22 ' A' ' 58' ' ' THR . 3.5 t -148.11 -162.78 1.62 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.591 -0.693 . . . . 0.0 109.655 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HD23 ' A' ' 7' ' ' LEU . 3.2 m -161.21 166.45 27.77 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.463 -0.773 . . . . 0.0 109.139 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.6 p -84.54 141.59 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.954 -1.091 . . . . 0.0 109.678 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 72' ' ' GLN . 0.1 OUTLIER -148.27 136.79 21.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.1 -1.0 . . . . 0.0 109.437 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 71' ' ' LYS . 7.1 tm0? . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.444 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.656 HG22 ' OD2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -43.21 126.02 3.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.39 161.57 18.98 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.489 -1.284 . . . . 0.0 110.771 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 4' ' ' THR . 12.2 t -124.39 104.16 8.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.27 -167.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 0.0 109.478 -178.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 44' ' ' VAL . 91.3 m -94.83 130.55 41.36 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.312 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.834 HD13 HG22 ' A' ' 45' ' ' VAL . 5.8 mp -108.51 139.31 43.45 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.154 -0.966 . . . . 0.0 109.189 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.651 ' HB3' ' HB3' ' A' ' 69' ' ' SER . . . -84.37 136.6 33.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.008 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.92 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 4.2 t -111.2 111.6 55.57 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.179 -0.951 . . . . 0.0 110.331 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 7.6 Cg_exo -64.12 170.91 8.38 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.128 1.594 . . . . 0.0 109.697 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 96.96 -62.86 1.05 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.439 -1.865 . . . . 0.0 108.439 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.538 ' HG2' ' CB ' ' A' ' 41' ' ' ARG . 4.5 mtm 61.58 -75.21 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.553 -0.969 . . . . 0.0 110.117 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -135.69 11.24 3.42 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.608 -0.683 . . . . 0.0 109.561 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 27.0 p -47.87 -27.67 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 158.93 41.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.594 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 69.25 49.77 0.59 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.947 . . . . 0.0 109.047 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HA ' ' CD2' ' A' ' 66' ' ' TYR . 70.7 m -85.1 -41.62 0.66 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.276 -0.89 . . . . 0.0 110.192 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.9 Cg_endo -66.99 -22.45 48.1 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.63 1.332 . . . . 0.0 110.494 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.785 HD12 ' HD2' ' A' ' 38' ' ' PHE . 1.3 tt -52.96 -43.21 46.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.083 -1.011 . . . . 0.0 108.606 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.519 ' HG1' ' HD2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -81.08 -35.39 31.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.616 -0.677 . . . . 0.0 109.86 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.831 HG11 HG13 ' A' ' 9' ' ' VAL . 79.2 t -50.05 -46.72 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.042 -1.036 . . . . 0.0 108.852 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.607 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.7 tttp -44.48 -64.81 0.61 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.892 -1.13 . . . . 0.0 109.883 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -55.56 -45.26 77.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.428 -0.795 . . . . 0.0 108.979 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.764 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -41.85 -45.97 3.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.615 -0.678 . . . . 0.0 109.337 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.953 ' CD1' HG21 ' A' ' 36' ' ' VAL . 3.4 mt -65.38 -72.18 0.16 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.798 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.8 OUTLIER -48.95 -18.28 0.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.66 -0.65 . . . . 0.0 111.075 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -100.57 -2.87 31.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.422 -1.424 . . . . 0.0 109.992 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.028 HG21 ' HA ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.56 -168.73 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.074 -1.017 . . . . 0.0 109.768 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -84.79 151.84 24.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.906 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . 84.87 -12.76 56.49 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 28' ' ' VAL . 49.7 t -36.79 135.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.649 -0.913 . . . . 0.0 110.351 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -144.61 -50.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' HG22 ' A' ' 46' ' ' THR . 0.1 OUTLIER -146.62 144.32 29.44 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 177.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.798 HG21 ' CA ' ' A' ' 26' ' ' SER . 38.6 t -143.43 120.53 5.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.138 -1.425 . . . . 0.0 112.181 -177.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -126.04 88.23 2.81 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG21 ' CD1' ' A' ' 25' ' ' LEU . 90.0 t -135.76 157.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.411 -0.806 . . . . 0.0 110.348 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -167.02 161.61 35.45 Favored Glycine 0 N--CA 1.48 1.621 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.319 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.785 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -101.31 -6.77 23.7 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 23.6 tt0 -44.58 -27.62 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 11.4 mtmt -138.38 -81.71 0.32 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' CB ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 169.86 68.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -151.11 136.25 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 118.165 -1.414 . . . . 0.0 111.09 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -122.08 88.25 2.9 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.407 -0.808 . . . . 0.0 109.612 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 6' ' ' THR . 60.3 t -84.59 117.68 30.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG22 HD13 ' A' ' 7' ' ' LEU . 32.3 m -157.5 161.92 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 117.957 -1.497 . . . . 0.0 111.405 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 46' ' ' THR . 10.7 t -126.4 96.47 4.7 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 57' ' ' LEU . 23.2 p90 -102.55 105.34 15.84 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 1.7 p-10 -85.48 60.12 6.05 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.656 ' OD2' HG22 ' A' ' 2' ' ' THR . 0.0 OUTLIER -6.84 -62.32 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.594 -178.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASP . 12.6 p 39.37 30.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER 163.35 -24.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -124.38 -147.9 0.38 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.163 -0.961 . . . . 0.0 109.557 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.71 169.67 3.52 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.341 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.604 HG23 ' HZ ' ' A' ' 47' ' ' PHE . 23.9 t -54.06 -59.97 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.156 -0.965 . . . . 0.0 109.093 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -55.23 -29.66 58.45 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 108.775 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -57.79 4.17 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.417 -0.802 . . . . 0.0 108.919 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.028 ' HA ' HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -64.51 -51.77 61.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.125 -0.984 . . . . 0.0 109.834 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.881 HG22 ' OG ' ' A' ' 68' ' ' SER . 11.5 p -55.14 -37.53 67.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -58.43 -54.65 44.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.09 -1.006 . . . . 0.0 109.152 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -50.49 -50.61 52.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.156 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.764 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 6.2 t -65.27 -40.89 94.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.286 -0.884 . . . . 0.0 109.186 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.01 -15.07 55.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.077 -1.014 . . . . 0.0 109.556 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.4 -28.36 56.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.65 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.58 10.3 15.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -0.952 . . . . 0.0 109.597 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 91.51 -28.58 8.13 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -109.21 115.92 55.91 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.452 -1.028 . . . . 0.0 108.693 179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.724 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.2 Cg_endo -116.8 -157.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 117.201 -1.399 . . . . 0.0 111.401 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.881 ' OG ' HG22 ' A' ' 58' ' ' THR . 77.5 p -144.82 -163.45 1.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.513 0.673 . . . . 0.0 109.717 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.651 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 5.2 t -165.33 177.96 7.2 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.498 -0.751 . . . . 0.0 109.32 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' N ' ' OG ' ' A' ' 69' ' ' SER . 14.9 p -99.41 143.95 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.983 -1.073 . . . . 0.0 109.593 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -154.45 149.69 27.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.047 . . . . 0.0 109.621 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.502 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.578 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.563 ' HA ' ' N ' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -41.26 122.38 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.79 . . . . 0.0 109.341 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.25 154.12 16.58 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 117.757 -1.577 . . . . 0.0 112.014 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.743 ' O ' HG23 ' A' ' 4' ' ' THR . 10.5 t -115.48 106.0 13.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 4' ' ' THR . 16.0 m -158.45 -167.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.836 -1.165 . . . . 0.0 110.353 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.991 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -98.26 153.54 18.43 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.541 -0.724 . . . . 0.0 109.485 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 2.1 mp -134.16 138.27 45.06 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.65 141.16 30.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.015 . . . . 0.0 109.11 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.028 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 5.6 t -115.32 117.62 40.74 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.115 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.7 Cg_exo -62.3 -163.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.978 1.515 . . . . 0.0 109.753 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 75.61 -58.5 2.95 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.594 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER 35.75 -90.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.9 -0.765 . . . . 0.0 111.076 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 11' ' ' GLY . 5.4 t -70.74 -29.28 65.49 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.574 -0.703 . . . . 0.0 110.67 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.525 ' SG ' ' CA ' ' A' ' 11' ' ' GLY . 18.8 p -42.44 164.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.531 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.583 ' O ' ' CE1' ' A' ' 38' ' ' PHE . . . -42.24 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.948 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -144.56 73.52 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 108.926 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 8.8 m -88.37 -51.31 0.4 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.253 -0.904 . . . . 0.0 110.365 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -58.14 -23.15 59.96 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.674 1.355 . . . . 0.0 110.349 -179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.948 HD12 ' HB1' ' A' ' 16' ' ' ALA . 7.8 mt -49.23 -46.3 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.174 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -80.78 -35.37 33.24 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.281 -0.887 . . . . 0.0 109.743 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.762 HG11 HG13 ' A' ' 9' ' ' VAL . 89.2 t -48.48 -47.11 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.086 -1.009 . . . . 0.0 108.837 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.588 ' HA ' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -49.49 -71.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.785 -1.197 . . . . 0.0 109.581 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -57.17 -40.49 77.4 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' CB ' HG22 ' A' ' 61' ' ' THR . . . -55.78 -36.4 67.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.576 -0.703 . . . . 0.0 109.394 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 HG21 ' A' ' 36' ' ' VAL . 41.5 mt -63.66 -71.83 0.16 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.061 -1.024 . . . . 0.0 108.508 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.657 ' HB2' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.8 -13.88 2.93 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.51 -0.744 . . . . 0.0 109.827 179.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 1.1 tttm -77.78 -23.72 49.09 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.786 -1.196 . . . . 0.0 109.722 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.3 t -78.61 -164.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 120.95 -1.094 . . . . 0.0 109.812 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.64 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -87.25 155.15 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 0.0 110.932 -178.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' HA2' ' HB ' ' A' ' 50' ' ' THR . . . 78.07 -7.43 44.23 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.657 HG23 ' HB2' ' A' ' 26' ' ' SER . 1.2 p -44.02 104.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 109.158 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -110.07 -43.26 4.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 108.564 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 46' ' ' THR . 10.8 tttm -127.29 148.28 50.23 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.6 p -140.49 89.13 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.904 -1.123 . . . . 0.0 111.207 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -120.93 88.31 2.91 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.662 -1.606 . . . . 0.0 106.662 177.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 43' ' ' ALA . 93.8 t -143.28 157.3 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.445 -0.784 . . . . 0.0 109.948 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.47 158.97 32.15 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 118.852 -1.642 . . . . 0.0 111.268 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CD2' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.02 -6.62 34.9 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.16 -27.41 0.4 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.315 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -142.59 -79.01 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.594 ' CB ' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 167.51 63.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -133.63 125.66 29.22 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.863 -1.135 . . . . 0.0 109.953 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.028 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -118.51 88.51 2.94 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.224 -0.922 . . . . 0.0 110.522 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 6' ' ' THR . 21.0 t -94.05 126.15 46.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 12.6 m -159.4 -169.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.738 -1.226 . . . . 0.0 109.707 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.616 HG23 ' HB ' ' A' ' 4' ' ' THR . 76.4 m -150.41 95.14 2.21 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.383 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.83 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 20.6 p90 -94.16 109.94 21.69 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 0.1 OUTLIER -91.7 43.89 1.16 Allowed 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.531 -1.268 . . . . 0.0 110.208 -177.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' N ' ' HA ' ' A' ' 2' ' ' THR . 50.0 t0 34.0 30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.093 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 48' ' ' ASP . 19.8 m -57.26 -18.71 17.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.599 -1.313 . . . . 0.0 107.826 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 3.4 mtpt -164.41 14.76 0.05 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 111.353 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -174.13 -159.1 0.09 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.536 -1.352 . . . . 0.0 110.321 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -152.74 173.74 14.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 0.0 110.044 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.83 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 46.2 t -41.64 -63.25 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.77 . . . . 0.0 110.155 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -42.7 -55.67 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.728 -179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 9.2 mttt -58.49 -55.36 36.06 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.136 -0.978 . . . . 0.0 109.052 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.784 ' HA ' HG11 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -51.41 -59.63 4.03 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 109.233 179.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -61.32 -36.2 79.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 55' ' ' GLN . 1.9 mtpt -57.77 -48.81 78.62 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 0.0 108.757 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.14 79.01 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.375 -0.828 . . . . 0.0 108.795 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' LEU . 32.7 p -68.94 -49.7 55.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.796 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.61 -24.45 61.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.812 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -68.77 -14.27 62.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.182 -0.949 . . . . 0.0 110.199 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.88 15.16 29.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 109.689 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.446 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 89.84 -27.98 7.6 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.622 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -114.37 117.36 43.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.395 -1.062 . . . . 0.0 108.868 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.4 Cg_exo -110.64 -155.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.555 1.292 . . . . 0.0 111.359 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -153.16 -162.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.531 0.681 . . . . 0.0 109.896 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -165.37 164.61 19.69 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.549 -0.719 . . . . 0.0 109.084 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 8.4 p -87.87 147.16 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.871 -1.143 . . . . 0.0 109.997 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -150.89 117.69 5.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' VAL . 32.4 mt-30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.413 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.569 ' CB ' ' HB2' ' A' ' 49' ' ' ASP . 8.0 t 38.43 31.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.634 -0.666 . . . . 0.0 109.487 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -168.11 -168.62 0.98 Allowed 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.624 -1.23 . . . . 0.0 110.659 -178.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.825 ' O ' HG13 ' A' ' 5' ' ' VAL . 11.1 t -95.24 120.36 35.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -165.94 -168.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.662 -1.274 . . . . 0.0 110.186 -178.307 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.534 ' O ' ' N ' ' A' ' 71' ' ' LYS . 6.7 m -95.77 137.53 34.7 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.289 -0.882 . . . . 0.0 109.34 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.805 HD22 HD22 ' A' ' 25' ' ' LEU . 3.5 mp -114.87 141.02 48.48 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.219 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 69' ' ' SER . . . -95.3 106.0 18.0 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.967 HG23 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -84.27 128.07 63.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 11' ' ' GLY . 5.3 Cg_exo -82.48 -4.67 11.67 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.814 1.428 . . . . 0.0 112.946 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 12' ' ' MET . . . -44.53 -63.26 2.52 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.561 ' C ' HG22 ' A' ' 13' ' ' THR . 25.0 mtp 46.25 109.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.065 -0.668 . . . . 0.0 110.948 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.561 HG22 ' C ' ' A' ' 12' ' ' MET . 5.4 t 39.29 37.93 0.3 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.395 -0.816 . . . . 0.0 110.247 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.717 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 24.9 t -88.65 23.7 2.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.72 -49.93 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.466 -0.771 . . . . 0.0 109.325 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -178.95 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.172 -0.955 . . . . 0.0 109.925 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 20' ' ' THR . 7.5 m -84.65 -48.42 0.64 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.947 -1.095 . . . . 0.0 109.584 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.588 ' HB3' HG21 ' A' ' 9' ' ' VAL . 3.5 Cg_exo -61.34 -34.45 87.27 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.448 1.236 . . . . 0.0 109.228 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.87 -29.03 10.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.606 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.38 -36.19 14.76 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 9' ' ' VAL . 10.5 t -45.98 -43.41 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 10.0 tttt -43.48 -67.28 0.29 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.836 0.827 . . . . 0.0 109.78 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 11.2 mttp -58.43 -48.97 78.96 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.478 -0.764 . . . . 0.0 109.093 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 61' ' ' THR . . . -42.75 -33.59 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 0.0 109.169 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 68' ' ' SER . 5.2 mt -72.68 -70.58 0.34 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.57 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -55.98 -25.84 45.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.92 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 1.5 mmmp? -77.2 -5.71 50.25 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.739 -1.226 . . . . 0.0 109.56 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 57' ' ' LEU . 1.4 p -89.98 -170.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.333 -0.855 . . . . 0.0 109.068 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 1.054 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 19.7 mm-40 -84.4 149.52 25.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.049 -1.032 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 48' ' ' ASP . . . 86.87 -16.17 48.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 1.5 p -41.86 104.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.388 -1.066 . . . . 0.0 109.913 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.471 ' C ' ' HG3' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -103.2 -35.05 8.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.583 ' N ' ' CG2' ' A' ' 46' ' ' THR . 7.1 mttm -155.85 178.16 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 26' ' ' SER . 8.4 p -158.74 148.77 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.601 -1.312 . . . . 0.0 111.376 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 45' ' ' VAL . 7.4 m-20 -164.96 88.61 0.47 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.892 HG21 ' CD1' ' A' ' 25' ' ' LEU . 56.6 t -142.45 163.48 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.293 -0.879 . . . . 0.0 110.277 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.85 160.09 33.64 Favored Glycine 0 N--CA 1.482 1.711 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.993 178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.92 -8.15 40.99 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.629 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 38' ' ' PHE . 2.5 mt-10 -44.61 -26.94 0.42 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -147.0 -69.24 0.25 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.4 ppt_? 153.08 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -133.14 125.96 30.66 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.047 -1.061 . . . . 0.0 109.324 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -116.28 88.17 2.84 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.544 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 35' ' ' ASP . 45.4 t -84.33 106.42 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 25' ' ' LEU . 11.5 m -145.14 172.08 5.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 120.88 -1.138 . . . . 0.0 109.478 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 46' ' ' THR . 10.0 t -133.29 105.37 6.94 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.909 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CE1' HD23 ' A' ' 57' ' ' LEU . 8.3 p90 -116.28 108.42 16.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.179 -1.785 . . . . 0.0 106.179 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.501 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -85.91 143.57 28.13 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -177.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 56.1 t0 -68.71 48.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.481 ' OG1' ' OD1' ' A' ' 48' ' ' ASP . 2.1 m -78.48 -26.41 46.0 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.471 ' CB ' ' OE1' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -161.1 20.79 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.653 -0.655 . . . . 0.0 109.922 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.054 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -152.9 -157.25 0.78 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.207 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 12.6 t -173.82 -160.64 0.11 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 70' ' ' VAL . 45.0 t -81.67 -67.21 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 120.909 -1.12 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 5.0 mm-40 -66.31 -18.86 65.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.32 -0.863 . . . . 0.0 109.36 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 27.9 mttp -81.69 -52.72 6.87 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.78 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -69.72 -43.71 71.8 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.117 -0.99 . . . . 0.0 108.794 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.964 HG22 ' O ' ' A' ' 68' ' ' SER . 33.6 p -59.47 -50.5 73.7 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 8.4 tttm -50.83 -44.43 59.24 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.166 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.43 89.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 108.943 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 57' ' ' LEU . 72.3 p -67.5 -51.02 56.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.068 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.786 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -58.55 -35.22 71.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.13 -28.94 67.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.59 9.43 16.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.68 7.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.797 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -113.02 113.26 49.57 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.33 -1.1 . . . . 0.0 108.921 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.786 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.3 Cg_exo -98.19 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.941 1.495 . . . . 0.0 111.306 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.964 ' O ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER 167.0 111.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.368 -0.833 . . . . 0.0 109.909 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.527 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -90.78 166.81 12.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.197 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG21 HG22 ' A' ' 54' ' ' VAL . 78.5 t -89.26 158.08 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.135 -0.978 . . . . 0.0 110.514 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -165.51 163.29 19.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.858 . . . . 0.0 109.504 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.479 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.564 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.3 OUTLIER -46.08 121.78 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.013 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.585 ' HG2' ' CZ ' ' A' ' 47' ' ' PHE . 20.4 pt20 -161.17 153.64 20.4 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.072 -1.451 . . . . 0.0 111.459 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 4' ' ' THR . 15.3 t -117.97 110.23 17.45 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -163.31 -167.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.681 -1.262 . . . . 0.0 109.661 -178.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 71' ' ' LYS . 87.8 m -95.57 151.75 19.05 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.876 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 mp -132.79 140.62 48.1 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.301 -0.875 . . . . 0.0 108.984 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.13 138.34 33.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.0 109.308 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.107 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 63.7 t -110.66 122.11 39.23 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.286 -0.884 . . . . 0.0 109.805 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.3 Cg_exo -75.84 175.85 10.77 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.984 1.518 . . . . 0.0 109.663 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 100.3 -57.57 0.77 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.522 ' HG2' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER 49.87 -89.16 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -1.022 . . . . 0.0 110.02 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 11' ' ' GLY . 8.2 t -101.07 49.46 0.88 Allowed 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.627 -0.671 . . . . 0.0 109.413 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 49.9 t -91.25 19.72 5.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.384 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 79.41 -49.93 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.582 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 19' ' ' ILE . . . -176.42 34.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.971 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.585 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 56.0 m -80.21 -38.57 1.14 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.0 109.469 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HB3' HG11 ' A' ' 9' ' ' VAL . 6.3 Cg_exo -70.61 -33.43 13.39 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.723 1.381 . . . . 0.0 110.333 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.639 ' CG1' ' CG ' ' A' ' 38' ' ' PHE . 22.8 mt -46.93 -26.79 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -90.06 -40.96 11.96 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.607 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 70.1 t -45.94 -49.65 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.583 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 9.1 tttt -45.35 -63.64 0.9 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.99 -1.069 . . . . 0.0 109.372 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -58.72 -30.17 67.24 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.896 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -53.05 -47.94 68.05 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.277 -0.889 . . . . 0.0 109.035 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.025 ' CD1' HG21 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -66.33 -71.96 0.18 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.885 ' CA ' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -48.34 -22.46 0.69 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.661 -0.649 . . . . 0.0 111.147 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . 8.9 pttt -94.91 -1.69 52.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.368 -1.457 . . . . 0.0 109.321 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.918 HG21 ' CB ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -90.43 -170.13 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.332 -0.855 . . . . 0.0 109.226 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' N ' HG13 ' A' ' 28' ' ' VAL . 9.0 mp0 -85.63 156.54 20.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 74.82 -0.83 56.3 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.847 HG21 ' O ' ' A' ' 26' ' ' SER . 54.9 t -45.77 89.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.462 -1.022 . . . . 0.0 110.123 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.6 OUTLIER -85.37 -44.39 12.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.644 -1.285 . . . . 0.0 108.438 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' N ' HG23 ' A' ' 46' ' ' THR . 1.3 ttpt -155.1 154.26 32.12 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.885 HG21 ' CA ' ' A' ' 26' ' ' SER . 13.5 t -148.29 131.56 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 118.35 -1.34 . . . . 0.0 111.922 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -139.33 88.33 2.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' CD1' ' A' ' 25' ' ' LEU . 98.6 t -135.06 161.16 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.015 -177.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.59 160.3 33.87 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 118.764 -1.684 . . . . 0.0 111.674 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.639 ' CG ' ' CG1' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -97.12 -12.66 22.85 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 115.24 -0.48 . . . . 0.0 109.754 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 38' ' ' PHE . 17.7 mt-10 -41.0 -28.83 0.09 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.512 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 4.6 mtmm -142.29 -72.98 0.31 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CD ' ' HG2' ' A' ' 12' ' ' MET . 0.0 OUTLIER 159.49 65.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -138.11 125.83 22.31 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 118.816 -1.154 . . . . 0.0 110.096 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.107 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -116.92 88.9 3.0 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.184 -0.948 . . . . 0.0 110.906 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 12.1 t -87.99 118.27 33.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HD13 ' A' ' 7' ' ' LEU . 17.2 m -158.25 166.99 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.46 -1.4 . . . . 0.0 110.656 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 46' ' ' THR . 5.1 t -135.44 102.48 5.15 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.292 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CZ ' ' HG2' ' A' ' 3' ' ' GLN . 29.2 p90 -98.79 117.23 32.8 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -97.77 52.82 1.09 Allowed 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.33 -176.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' HB2' ' N ' ' A' ' 2' ' ' THR . 64.5 t0 33.61 29.76 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.78 -0.575 . . . . 0.0 111.608 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.545 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 35.7 m -58.83 -17.43 23.63 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.676 -1.265 . . . . 0.0 108.144 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.57 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -167.59 18.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 111.107 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 29' ' ' GLU . . . -176.75 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.643 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.09 175.54 10.93 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.09 -1.006 . . . . 0.0 109.829 -179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HA ' HD21 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -57.65 -48.4 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.285 -0.884 . . . . 0.0 110.263 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 mm-40 -68.84 -37.85 79.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.96 . . . . 0.0 109.168 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 7.4 mttt -65.24 -50.24 66.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.339 -0.851 . . . . 0.0 109.242 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.918 ' CB ' HG21 ' A' ' 28' ' ' VAL . 3.2 pp -65.78 -52.38 51.36 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.071 -1.018 . . . . 0.0 109.333 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.906 ' N ' HD12 ' A' ' 57' ' ' LEU . 13.2 p -53.33 -48.77 68.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.137 -0.977 . . . . 0.0 109.187 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 58' ' ' THR . 7.0 ttmm -46.04 -54.93 7.62 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 108.973 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -54.7 -42.83 71.93 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.902 . . . . 0.0 108.833 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.896 HG22 ' HB1' ' A' ' 24' ' ' ALA . 11.3 p -61.55 -46.59 89.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 108.988 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.677 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -67.21 -9.89 44.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.826 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -81.54 -11.38 59.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.945 . . . . 0.0 109.828 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.73 12.9 25.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.907 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.452 ' C ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.85 -28.98 7.21 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -111.96 109.49 54.88 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.468 -1.019 . . . . 0.0 108.61 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.677 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -111.01 -156.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.606 1.319 . . . . 0.0 111.267 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.54 -164.01 1.85 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.574 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -165.17 177.1 7.91 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.327 -0.858 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 2.8 p -95.86 146.23 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.133 . . . . 0.0 109.437 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.3 OUTLIER -147.13 118.3 7.78 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.994 -1.066 . . . . 0.0 109.544 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.423 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.44 ' O ' ' OD1' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.256 0.55 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.587 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 1.5 t -65.83 170.16 5.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.666 ' CD ' HG22 ' A' ' 54' ' ' VAL . 1.8 mp0 -129.49 112.21 13.54 Favored 'General case' 0 C--N 1.313 -0.988 0 O-C-N 120.556 -1.34 . . . . 0.0 109.682 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 4' ' ' THR . 6.4 t -142.67 78.68 1.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -162.8 -167.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.052 -1.03 . . . . 0.0 109.127 -178.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.045 HG23 HG22 ' A' ' 44' ' ' VAL . 1.4 m -85.64 155.12 21.25 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.271 -0.893 . . . . 0.0 109.171 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.965 HD13 HG22 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -133.61 141.15 47.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.31 -0.868 . . . . 0.0 109.024 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' SER . . . -84.79 137.18 33.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.147 -0.971 . . . . 0.0 109.511 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.787 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.1 t -115.65 125.07 29.12 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 109.97 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 2.6 Cg_exo -81.79 162.48 18.7 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.997 1.525 . . . . 0.0 109.601 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 17' ' ' CYS . . . 102.41 -60.83 0.52 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.444 -1.862 . . . . 0.0 108.444 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER 62.04 -72.91 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.595 -0.944 . . . . 0.0 110.295 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.6 OUTLIER -137.36 6.83 2.81 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.57 -0.706 . . . . 0.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 22.1 p -44.22 -28.21 0.49 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.089 -1.007 . . . . 0.0 109.269 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 156.71 56.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 63.76 53.66 1.94 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.957 . . . . 0.0 108.904 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HA ' ' CG ' ' A' ' 66' ' ' TYR . 1.3 m -79.28 -66.06 0.28 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.616 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.787 ' HB3' HG11 ' A' ' 9' ' ' VAL . 3.6 Cg_exo -54.09 -18.3 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.604 1.318 . . . . 0.0 110.862 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.708 HD12 ' CD2' ' A' ' 38' ' ' PHE . 2.0 tt -50.62 -48.79 26.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.032 -1.042 . . . . 0.0 109.065 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 19' ' ' ILE . 2.5 m -79.73 -36.94 36.63 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.976 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HG13 ' A' ' 9' ' ' VAL . 85.3 t -46.96 -42.45 6.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.044 -1.035 . . . . 0.0 108.448 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' CG ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -49.25 -70.23 0.09 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.029 -1.044 . . . . 0.0 109.854 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -48.45 -41.36 29.21 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 1.115 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -47.85 -60.73 2.37 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.575 -0.703 . . . . 0.0 110.348 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.782 HD22 HG21 ' A' ' 45' ' ' VAL . 7.5 mt -51.98 -58.21 7.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.824 -1.172 . . . . 0.0 110.713 -178.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -78.93 10.91 2.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 111.108 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HG2' ' HA ' ' A' ' 24' ' ' ALA . 17.5 ptmt -124.01 -32.5 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.566 -1.333 . . . . 0.0 110.17 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.115 HG23 ' O ' ' A' ' 24' ' ' ALA . 2.3 t -64.6 -162.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.558 -1.339 . . . . 0.0 107.65 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.973 ' CB ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mt-10 -85.03 144.45 28.26 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.584 -1.322 . . . . 0.0 109.877 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 48' ' ' ASP . . . 98.76 -4.49 59.48 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 26' ' ' SER . 95.8 t -40.97 159.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.9 -39.41 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -159.9 173.94 15.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -165.62 119.94 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 117.549 -1.66 . . . . 0.0 112.593 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' VAL . 39.5 t0 -135.95 85.12 2.13 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.613 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.03 157.04 6.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.435 -0.791 . . . . 0.0 110.374 -176.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -167.03 167.38 39.75 Favored Glycine 0 N--CA 1.483 1.833 0 C-N-CA 119.191 -1.481 . . . . 0.0 111.325 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.708 ' CD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -102.29 -5.25 24.47 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 6.4 tt0 -43.63 -28.45 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 12.9 mtmm -129.61 -85.02 0.55 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HB2' ' CG ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 173.66 59.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 44.6 mt-10 -156.42 150.83 25.55 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.158 -1.417 . . . . 0.0 110.44 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.684 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -136.19 113.71 10.9 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.92 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.045 HG22 HG23 ' A' ' 6' ' ' THR . 2.7 t -106.94 128.32 61.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.965 HG22 HD13 ' A' ' 7' ' ' LEU . 18.5 m -157.86 176.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.245 -1.534 . . . . 0.0 110.427 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 32' ' ' SER . 4.8 m -140.09 102.14 4.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 57' ' ' LEU . 28.2 p90 -122.06 -169.62 1.92 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.785 ' OD1' HG23 ' A' ' 50' ' ' THR . 0.0 OUTLIER -162.93 156.74 20.26 Favored 'General case' 0 C--N 1.279 -2.482 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.927 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 1.4 m-20 -73.82 12.04 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.697 -0.627 . . . . 0.0 111.817 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.785 HG23 ' OD1' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -44.79 -36.28 3.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.714 -1.241 . . . . 0.0 108.397 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -146.65 13.17 1.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.65 -0.656 . . . . 0.0 109.341 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.973 ' HB2' ' CB ' ' A' ' 29' ' ' GLU . . . -151.31 -155.55 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.057 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -164.44 168.4 18.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.466 -0.771 . . . . 0.0 109.051 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.666 HG22 ' CD ' ' A' ' 3' ' ' GLN . 14.4 t -59.22 -52.39 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.129 -0.982 . . . . 0.0 109.338 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -59.42 -36.52 76.04 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 108.984 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -58.1 -58.58 7.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.221 -0.924 . . . . 0.0 109.181 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.086 ' O ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -56.24 -63.03 1.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.091 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.479 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 9.0 p -53.62 -47.75 69.96 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.356 -0.84 . . . . 0.0 109.814 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 18.1 tptt -53.31 -49.74 66.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.85 -1.156 . . . . 0.0 108.471 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.39 -40.6 96.13 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.086 HG23 ' O ' ' A' ' 57' ' ' LEU . 28.6 p -59.05 -51.88 68.14 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -63.14 -17.3 62.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.2 t0 -80.0 -4.54 53.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.907 . . . . 0.0 109.788 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.26 6.99 19.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.587 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.464 ' C ' ' CD1' ' A' ' 66' ' ' TYR . . . 100.56 -35.5 4.78 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.966 -1.653 . . . . 0.0 108.966 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 17' ' ' CYS . 1.1 m-85 -114.39 120.65 37.7 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.521 -0.988 . . . . 0.0 108.66 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.689 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.5 Cg_endo -114.32 -157.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.619 1.326 . . . . 0.0 111.213 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.577 ' OG ' HG11 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -157.63 -166.29 1.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.7 0.762 . . . . 0.0 109.938 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.647 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -165.3 -170.85 1.99 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.441 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 13.3 p -103.74 150.39 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.851 -1.155 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 6' ' ' THR . 24.9 tttm -157.64 137.03 11.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.073 -1.017 . . . . 0.0 109.53 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.384 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.577 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.569 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -41.7 127.94 3.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.385 -0.822 . . . . 0.0 109.412 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -159.26 153.74 24.14 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 118.118 -1.433 . . . . 0.0 111.85 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 9.7 t -124.83 98.38 5.68 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.6 -167.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.525 -1.359 . . . . 0.0 110.249 -177.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 71' ' ' LYS . 92.7 m -96.81 111.69 23.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.499 -0.751 . . . . 0.0 109.591 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD22 ' A' ' 25' ' ' LEU . 4.1 mp -83.92 136.66 34.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.761 ' HB2' ' CD ' ' A' ' 71' ' ' LYS . . . -83.88 125.37 31.92 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.225 -0.922 . . . . 0.0 109.441 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 18' ' ' PRO . 2.4 t -93.07 145.17 29.59 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.337 -0.852 . . . . 0.0 109.111 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -98.03 2.79 1.38 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.678 1.357 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . -80.98 9.27 54.21 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.501 ' HB3' ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -37.99 -67.68 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.52 -0.988 . . . . 0.0 111.046 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 13' ' ' THR . 3.5 t -79.81 46.77 0.81 Allowed 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.687 -0.633 . . . . 0.0 110.292 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 17' ' ' CYS . 11.9 t -127.57 136.77 52.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 38' ' ' PHE . . . -45.43 -29.0 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.546 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 38' ' ' PHE . . . 176.94 54.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.914 . . . . 0.0 109.286 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 17.7 m -86.79 -49.88 0.47 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.882 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.783 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -57.94 -23.1 58.05 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.711 1.374 . . . . 0.0 109.529 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 20' ' ' THR . 5.7 tp -49.85 -45.8 22.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.571 ' OG1' ' CG ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -72.38 -43.7 63.58 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 9' ' ' VAL . 48.4 t -46.44 -48.73 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' HA ' ' CG1' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -44.02 -66.87 0.33 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.215 -0.928 . . . . 0.0 109.091 178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 60.5 mttt -60.22 -31.73 70.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -57.34 -42.91 82.85 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.264 -0.898 . . . . 0.0 108.94 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.9 ' O ' HG12 ' A' ' 28' ' ' VAL . 38.3 mt -63.82 -69.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.177 -0.952 . . . . 0.0 108.846 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.591 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -56.94 -31.73 65.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.404 -0.81 . . . . 0.0 110.658 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' CG ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -78.56 -1.79 35.69 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.611 -1.305 . . . . 0.0 109.108 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 25' ' ' LEU . 1.3 p -89.66 -172.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.415 -0.803 . . . . 0.0 108.946 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 1.001 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 5.8 mt-10 -84.85 147.03 27.01 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.112 -0.993 . . . . 0.0 109.58 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 50' ' ' THR . . . 84.82 -8.71 68.34 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -43.34 93.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.357 -1.084 . . . . 0.0 109.536 179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 30' ' ' GLY . 0.1 OUTLIER -91.65 -50.08 5.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.986 -1.071 . . . . 0.0 108.456 179.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 45' ' ' VAL . 8.5 tptt -135.71 145.17 46.41 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 34' ' ' VAL . 4.3 p -134.27 108.03 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.917 -1.114 . . . . 0.0 111.403 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -134.67 85.93 2.22 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 176.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -145.66 163.17 11.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.565 -0.71 . . . . 0.0 110.271 -176.317 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 36' ' ' VAL . . . -166.39 165.52 38.33 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 118.577 -1.773 . . . . 0.0 112.503 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.24 -4.99 44.77 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.462 -0.869 . . . . 0.0 109.694 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.6 tp10 -45.47 -25.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 3.7 mtpm? -142.72 -68.06 0.36 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 151.26 53.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 mt-10 -134.19 143.17 47.71 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.618 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.599 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -134.52 98.2 4.01 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 117.777 -1.569 . . . . 0.0 112.688 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 35' ' ' ASP . 20.6 t -83.73 89.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 33' ' ' LYS . 88.1 t -133.99 163.61 36.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.347 -0.845 . . . . 0.0 108.734 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' HB ' ' A' ' 4' ' ' THR . 72.9 m -129.29 99.22 5.14 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.84 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.643 ' CG ' ' CD2' ' A' ' 57' ' ' LEU . 16.4 p90 -97.26 110.73 23.22 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -96.86 50.87 1.12 Allowed 'General case' 0 C--N 1.283 -2.293 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.15 -176.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.569 ' HB2' ' N ' ' A' ' 2' ' ' THR . 49.1 t0 35.02 27.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.905 -0.497 . . . . 0.0 111.464 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.552 ' CB ' ' HA2' ' A' ' 30' ' ' GLY . 26.3 m -55.24 -22.33 17.68 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.305 -1.497 . . . . 0.0 107.12 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.555 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 2.1 mtpt -169.56 20.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.722 -0.611 . . . . 0.0 110.569 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.001 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -153.17 -161.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 0.0 110.035 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.525 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -159.27 -176.87 6.06 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 58' ' ' THR . 24.8 t -62.35 -60.86 2.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.853 -1.155 . . . . 0.0 109.117 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -71.26 -24.57 62.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.437 -0.789 . . . . 0.0 109.067 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HB2' ' N ' ' A' ' 53' ' ' SER . 1.3 mtpt -78.63 -51.91 9.2 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.339 -0.85 . . . . 0.0 109.159 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.781 ' O ' HG23 ' A' ' 61' ' ' THR . 0.4 OUTLIER -68.11 -42.14 80.7 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.051 -1.031 . . . . 0.0 108.943 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 54' ' ' VAL . 64.4 p -63.7 -53.03 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.428 -0.795 . . . . 0.0 109.256 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 58' ' ' THR . 8.0 tptm -45.12 -48.99 12.13 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.095 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -56.81 -37.35 71.06 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.781 HG23 ' O ' ' A' ' 57' ' ' LEU . 16.3 p -70.81 -46.04 63.52 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.852 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -60.65 -19.39 58.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.442 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.3 -35.68 79.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.844 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -84.76 12.09 7.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.632 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 90.2 -21.77 29.69 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.571 ' CG ' ' OG1' ' A' ' 20' ' ' THR . 0.2 OUTLIER -109.29 114.94 57.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.32 -1.106 . . . . 0.0 109.186 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.852 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.7 Cg_endo -111.34 -156.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.609 1.32 . . . . 0.0 111.249 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.3 p -161.7 -167.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.337 -0.852 . . . . 0.0 109.792 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -162.56 -169.53 2.13 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.631 -0.668 . . . . 0.0 109.29 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.87 143.61 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.982 -1.074 . . . . 0.0 109.554 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.761 ' CD ' ' HB2' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -165.1 179.6 6.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.054 -1.028 . . . . 0.0 109.536 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HG3' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.451 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.584 ' O ' ' CG2' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.647 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 5.0 t 45.27 175.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.175 0.512 . . . . 0.0 110.878 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.636 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -130.12 89.18 2.76 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.303 -1.498 . . . . 0.0 109.023 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.809 ' O ' HG23 ' A' ' 4' ' ' THR . 9.1 t -119.77 80.11 1.54 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -162.46 -166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.032 -1.042 . . . . 0.0 109.419 -178.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.003 HG23 HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -86.9 157.89 19.42 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.284 -0.885 . . . . 0.0 109.428 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.031 HD13 HG22 ' A' ' 45' ' ' VAL . 1.9 mp -140.11 150.2 44.0 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.285 -0.884 . . . . 0.0 108.998 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.07 144.52 29.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.19 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.878 HG12 ' HB3' ' A' ' 18' ' ' PRO . 44.8 t -120.9 80.03 33.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.381 -0.824 . . . . 0.0 110.099 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' PRO . 3.2 Cg_exo -42.79 165.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.965 1.508 . . . . 0.0 109.864 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' THR . . . 108.66 -58.88 0.38 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 67.68 -59.97 0.4 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.477 -1.013 . . . . 0.0 109.98 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER 175.71 35.36 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.544 -0.722 . . . . 0.0 109.608 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 4.7 p -60.71 -15.47 29.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.2 -0.937 . . . . 0.0 109.388 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 14' ' ' CYS . . . 160.64 -38.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 15' ' ' ALA . . . 162.41 43.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.378 -0.826 . . . . 0.0 108.985 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 66' ' ' TYR . 5.2 m -88.06 -42.2 0.49 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 110.081 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.878 ' HB3' HG12 ' A' ' 9' ' ' VAL . 1.7 Cg_endo -72.53 -34.22 7.63 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.689 1.363 . . . . 0.0 110.467 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.604 HG13 ' CG ' ' A' ' 38' ' ' PHE . 61.0 mt -48.01 -32.04 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.956 -1.09 . . . . 0.0 108.268 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -85.75 -40.18 16.36 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.687 ' O ' HD12 ' A' ' 25' ' ' LEU . 77.9 t -44.88 -51.64 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 108.721 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.04 -67.42 0.29 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 109.652 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.7 mttt -56.11 -46.12 79.25 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.841 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -44.54 -41.7 6.67 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.668 -0.645 . . . . 0.0 109.393 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.89 HD13 HG21 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -62.87 -70.27 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.8 -8.75 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.124 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -81.31 -35.54 30.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.992 -1.068 . . . . 0.0 109.718 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 24' ' ' ALA . 1.4 t -74.24 -167.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.032 -1.042 . . . . 0.0 109.628 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 1.03 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . 9.0 mp0 -84.07 161.08 20.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -0.899 . . . . 0.0 110.19 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 86.33 -20.49 21.75 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 2.5 p -41.17 156.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -1.041 . . . . 0.0 110.07 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -168.49 -53.87 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -133.78 127.67 33.22 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.8 p -132.51 90.23 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 120.572 -1.33 . . . . 0.0 111.957 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -97.9 87.7 4.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.023 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.89 HG21 HD13 ' A' ' 25' ' ' LEU . 45.4 t -136.94 157.74 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.627 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.36 160.84 34.5 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 118.596 -1.764 . . . . 0.0 111.438 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' HG13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -96.06 -11.57 26.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' PHE . 34.3 tt0 -43.15 -28.44 0.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.566 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -142.05 -66.79 0.4 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 1.2 ptp180 148.34 65.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -140.8 130.56 24.3 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.919 -1.113 . . . . 0.0 109.891 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.832 ' CA ' HG22 ' A' ' 36' ' ' VAL . . . -120.4 89.38 3.12 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.176 -0.953 . . . . 0.0 111.158 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.003 HG22 HG23 ' A' ' 6' ' ' THR . 20.4 t -91.88 107.17 18.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.031 HG22 HD13 ' A' ' 7' ' ' LEU . 5.8 m -142.39 165.34 16.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.793 -1.192 . . . . 0.0 110.372 -177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.3 m -129.75 92.42 3.32 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CD1' ' CD1' ' A' ' 57' ' ' LEU . 8.3 p90 -113.62 -176.76 2.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 2' ' ' THR . 1.5 p-10 -159.97 152.5 21.09 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 116.437 -2.105 . . . . 0.0 111.789 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.7 p-10 -76.37 -4.21 41.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.86 -0.525 . . . . 0.0 110.562 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.451 ' C ' ' O ' ' A' ' 49' ' ' ASP . 51.8 m -44.94 -27.21 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.589 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 20.4 tttt -143.8 11.7 1.63 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.622 -0.674 . . . . 0.0 109.19 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . . . -157.22 -154.24 0.45 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.322 -0.861 . . . . 0.0 109.57 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -158.51 166.05 33.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.395 -0.816 . . . . 0.0 109.401 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HZ ' ' A' ' 47' ' ' PHE . 91.4 t -66.89 -52.47 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 2.9 mp0 -60.51 -39.13 86.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.248 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -55.06 -55.38 31.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.21 -0.931 . . . . 0.0 108.906 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.753 ' HA ' HG21 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -58.53 -65.16 0.7 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.49 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 2.1 p -53.01 -34.02 54.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.355 -0.841 . . . . 0.0 109.499 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 3.2 ttmt -62.28 -55.72 25.54 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.267 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.46 -48.33 47.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 0.0 108.908 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.775 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 7.2 t -68.02 -41.57 81.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 108.809 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -65.97 -8.98 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.035 -1.041 . . . . 0.0 109.623 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -89.47 0.67 56.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.972 . . . . 0.0 109.972 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.89 10.67 12.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . 95.47 -32.38 6.29 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -109.97 114.64 56.0 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.686 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 3.3 Cg_exo -113.14 -156.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.601 1.316 . . . . 0.0 111.739 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB3' HG22 ' A' ' 58' ' ' THR . 33.8 t -145.84 -173.13 4.07 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.48 0.657 . . . . 0.0 109.232 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.72 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -165.19 162.73 20.16 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.365 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.478 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 14.0 p -84.66 153.07 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.902 -1.124 . . . . 0.0 109.798 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -158.37 124.34 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.061 -1.024 . . . . 0.0 109.575 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.446 -179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.318 0.58 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.599 ' CB ' ' HB2' ' A' ' 48' ' ' ASP . 0.5 OUTLIER -46.78 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.591 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.634 ' CB ' ' CE2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -119.84 89.64 3.17 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 120.767 -1.208 . . . . 0.0 108.743 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.821 HG23 ' O ' ' A' ' 4' ' ' THR . 12.9 t -121.48 81.36 1.79 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 4' ' ' THR . 0.3 OUTLIER -161.58 -166.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 109.898 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.009 HG23 HG22 ' A' ' 44' ' ' VAL . 1.8 m -93.55 135.72 34.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.376 -0.827 . . . . 0.0 109.1 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.912 HD13 HG22 ' A' ' 45' ' ' VAL . 6.2 mp -113.26 160.68 18.05 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.408 -0.808 . . . . 0.0 109.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -94.61 140.46 29.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 109.479 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.732 HG22 ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -111.98 81.81 3.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 11' ' ' GLY . 3.2 Cg_exo -42.93 -24.32 0.41 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.222 1.643 . . . . 0.0 111.275 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 13' ' ' THR . . . -41.22 -54.6 3.79 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.679 ' C ' HG22 ' A' ' 13' ' ' THR . 42.5 mtp 66.39 -61.61 0.29 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.471 -1.017 . . . . 0.0 109.487 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.679 HG22 ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER 165.29 34.69 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.163 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.707 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 16.8 p -56.65 -22.56 35.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.782 -1.199 . . . . 0.0 108.841 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . 156.63 47.46 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 78.52 36.37 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 1.6 m -78.05 -61.96 0.55 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.413 -0.804 . . . . 0.0 109.893 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.602 ' HB3' ' CG1' ' A' ' 9' ' ' VAL . 4.4 Cg_endo -48.98 -26.27 9.95 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.716 1.377 . . . . 0.0 109.837 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 16' ' ' ALA . 1.4 tt -51.88 -39.86 26.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.595 ' HB ' ' CD1' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -80.2 -39.18 29.68 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.559 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.669 HG11 HG13 ' A' ' 9' ' ' VAL . 80.9 t -46.02 -48.19 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.988 -1.07 . . . . 0.0 108.234 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.66 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -43.62 -70.01 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.322 1.058 . . . . 0.0 109.525 179.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -55.86 -41.16 73.94 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -45.83 -46.64 15.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.734 -0.604 . . . . 0.0 109.942 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.92 -64.75 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.084 . . . . 0.0 108.86 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.805 ' HA ' HG13 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -69.77 7.19 0.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.997 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.28 -34.09 12.98 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.005 -1.06 . . . . 0.0 108.231 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.98 HG11 ' HA ' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -80.1 -160.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.333 -0.854 . . . . 0.0 109.627 -179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 0.4 OUTLIER -86.21 171.16 11.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.525 -0.734 . . . . 0.0 110.433 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 47' ' ' PHE . . . 77.36 -7.68 37.17 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.805 HG13 ' HA ' ' A' ' 26' ' ' SER . 7.0 t -42.76 166.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 0.0 109.651 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.71 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.071 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.37 166.17 25.4 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' VAL . 9.9 p -159.42 128.63 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.681 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -147.56 88.08 1.68 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 177.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.895 HG21 HD13 ' A' ' 25' ' ' LEU . 62.5 t -140.82 160.15 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.493 -0.754 . . . . 0.0 109.899 -177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.97 160.85 34.65 Favored Glycine 0 N--CA 1.483 1.774 0 C-N-CA 118.236 -1.935 . . . . 0.0 112.227 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -93.75 -8.89 39.42 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.816 -0.692 . . . . 0.0 109.467 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 38' ' ' PHE . 9.5 tt0 -44.4 -26.82 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.55 ' O ' ' CB ' ' A' ' 41' ' ' ARG . 2.0 mppt? -147.04 -68.49 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 152.32 61.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 55.2 mt-10 -130.38 122.9 28.69 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.389 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.827 ' HA ' HG22 ' A' ' 36' ' ' VAL . . . -112.47 87.05 2.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.123 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.009 HG22 HG23 ' A' ' 6' ' ' THR . 16.4 t -88.33 110.92 21.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.912 HG22 HD13 ' A' ' 7' ' ' LEU . 30.9 m -147.29 165.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 120.697 -1.252 . . . . 0.0 109.973 -178.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 3.8 m -131.99 95.96 3.81 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.531 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.658 ' CE2' HD21 ' A' ' 57' ' ' LEU . 2.3 p90 -117.28 -178.06 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -160.8 165.47 30.23 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 116.787 -1.965 . . . . 0.0 111.305 -179.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 8.7 p-10 -69.15 3.58 2.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.597 -0.689 . . . . 0.0 111.821 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.49 HG22 ' OD1' ' A' ' 48' ' ' ASP . 4.4 t -44.82 -26.45 0.4 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.782 -1.198 . . . . 0.0 109.095 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 49' ' ' ASP . 1.6 mmmp? -163.26 18.84 0.08 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.573 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.957 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . . . -165.33 -156.36 0.28 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.89 -1.131 . . . . 0.0 110.202 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 54' ' ' VAL . 1.0 OUTLIER -164.61 175.29 9.93 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 ' N ' ' OG ' ' A' ' 53' ' ' SER . 22.0 t -69.64 -57.11 9.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.118 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 4.3 mm-40 -63.79 -25.25 68.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.824 . . . . 0.0 108.949 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.73 -58.78 3.07 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.196 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.031 ' O ' HG23 ' A' ' 61' ' ' THR . 2.7 pp -62.07 -44.41 96.73 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.157 -0.964 . . . . 0.0 109.402 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.865 ' N ' HD12 ' A' ' 57' ' ' LEU . 34.4 p -60.43 -52.21 66.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.239 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -45.41 -51.48 11.31 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.499 -0.88 . . . . 0.0 108.977 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.12 -43.45 95.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 0.0 108.583 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.031 HG23 ' O ' ' A' ' 57' ' ' LEU . 20.7 p -61.32 -43.57 98.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.822 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -61.19 -38.47 86.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.52 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -67.11 -8.04 27.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.835 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.584 ' O ' ' CE1' ' A' ' 66' ' ' TYR . . . -98.99 4.58 47.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.603 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.71 -3.48 65.38 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.595 ' CD1' ' HB ' ' A' ' 20' ' ' THR . 0.0 OUTLIER -146.64 115.37 4.47 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.268 -1.136 . . . . 0.0 108.777 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.822 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.6 Cg_endo -108.44 -159.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.708 1.373 . . . . 0.0 111.264 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.511 ' OG ' ' CG1' ' A' ' 21' ' ' VAL . 0.3 OUTLIER -163.76 -175.79 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.609 -0.682 . . . . 0.0 109.479 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 7' ' ' LEU . 19.7 m -156.11 -175.67 5.55 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 9.6 p -99.81 152.43 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.08 -1.013 . . . . 0.0 109.625 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.563 ' N ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.61 132.52 11.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.148 -0.97 . . . . 0.0 109.5 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.42 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.589 ' O ' ' CZ ' ' A' ' 47' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.557 ' N ' ' HB2' ' A' ' 49' ' ' ASP . 1.3 t -38.13 109.06 0.09 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.663 -0.648 . . . . 0.0 109.665 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -165.34 149.95 8.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.577 -1.249 . . . . 0.0 111.351 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.63 ' CA ' HG23 ' A' ' 46' ' ' THR . 6.3 t -95.04 118.42 31.83 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -157.91 -167.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.673 -1.267 . . . . 0.0 110.008 -177.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.9 HG23 HG22 ' A' ' 44' ' ' VAL . 46.7 m -101.97 147.38 26.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.326 -0.859 . . . . 0.0 109.588 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 1.4 mp -129.04 132.27 47.46 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.624 ' HB3' ' HB2' ' A' ' 69' ' ' SER . . . -84.16 137.03 33.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.873 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 11.1 t -98.05 140.74 22.1 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -91.71 -0.56 4.46 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.747 1.393 . . . . 0.0 110.529 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.723 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -86.64 18.37 34.62 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -39.14 -82.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.619 -0.93 . . . . 0.0 110.113 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 13' ' ' THR . 2.4 t -81.26 45.01 0.81 Allowed 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.813 -0.555 . . . . 0.0 109.927 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 2.4 t -107.91 162.23 14.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.123 -0.986 . . . . 0.0 109.341 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.671 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -69.55 59.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 15' ' ' ALA . . . 74.68 45.46 0.17 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 77.9 m -83.79 -42.33 0.78 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.858 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.862 ' HB3' HG11 ' A' ' 9' ' ' VAL . 4.1 Cg_exo -64.63 -23.19 63.99 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.633 1.333 . . . . 0.0 110.102 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.467 ' N ' ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -53.48 -32.55 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.496 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -89.18 -38.67 14.11 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 HG13 ' A' ' 9' ' ' VAL . 98.4 t -46.98 -44.31 7.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.609 ' CB ' ' HB ' ' A' ' 36' ' ' VAL . 8.6 tttm -46.6 -70.54 0.09 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.085 -1.01 . . . . 0.0 109.255 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.562 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 10.9 ptpt -58.62 -40.38 83.16 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB1' HG22 ' A' ' 61' ' ' THR . . . -45.82 -44.22 13.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.433 -0.792 . . . . 0.0 108.906 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.886 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -67.8 -74.97 0.11 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.667 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -41.51 -23.95 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.0 110.525 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -80.74 -10.48 59.72 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.672 -1.268 . . . . 0.0 110.637 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.057 HG11 ' HA ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -90.27 -164.27 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.818 -1.177 . . . . 0.0 110.092 -179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.657 ' H ' HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -92.43 135.7 33.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 0.0 110.596 -178.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 32' ' ' SER . . . 84.59 -27.45 4.74 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' C ' ' A' ' 25' ' ' LEU . 1.7 t -65.45 67.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -1.175 . . . . 0.0 108.975 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' GLY . 1.6 m -77.47 -37.61 51.02 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.554 ' HB3' ' CB ' ' A' ' 46' ' ' THR . 16.6 tttm -89.68 143.21 27.0 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.339 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.569 ' HA ' HG12 ' A' ' 45' ' ' VAL . 2.9 p -141.77 88.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.508 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 44' ' ' VAL . 12.8 t70 -119.91 87.36 2.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 43' ' ' ALA . 89.1 t -144.47 157.61 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 110.143 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.88 158.02 30.79 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 118.818 -1.658 . . . . 0.0 111.326 178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CG ' ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.09 -6.22 39.06 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' OE1' ' HG3' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.48 -27.62 0.48 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -141.76 -82.87 0.2 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CG ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 173.46 58.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.57 128.8 39.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.726 -1.233 . . . . 0.0 110.464 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.873 ' HB2' ' CG2' ' A' ' 9' ' ' VAL . . . -121.53 88.59 2.97 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.197 -0.94 . . . . 0.0 110.062 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.9 HG22 HG23 ' A' ' 6' ' ' THR . 42.4 t -92.99 129.05 44.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 34' ' ' VAL . 17.2 m -159.77 -169.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.9 -1.125 . . . . 0.0 109.353 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.63 HG23 ' CA ' ' A' ' 4' ' ' THR . 91.6 m -142.64 108.6 5.18 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 109.93 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.878 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 2.6 p90 -103.18 107.36 18.14 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.538 ' HA ' ' OG1' ' A' ' 2' ' ' THR . 0.0 OUTLIER -93.62 35.64 1.12 Allowed 'General case' 0 C--N 1.283 -2.312 0 CA-C-O 122.239 1.018 . . . . 0.0 109.966 -176.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HB2' ' N ' ' A' ' 2' ' ' THR . 4.3 t70 34.01 29.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.227 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.573 HG22 ' HG3' ' A' ' 51' ' ' LYS . 2.6 m -70.59 -14.77 62.62 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.84 -1.162 . . . . 0.0 108.407 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG22 ' A' ' 50' ' ' THR . 3.8 mttt -161.0 14.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 0.0 110.909 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -179.72 -156.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.74 -1.225 . . . . 0.0 109.695 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.461 ' HA ' ' CE2' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.0 172.28 15.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.575 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.878 HG23 ' CZ ' ' A' ' 47' ' ' PHE . 55.6 t -58.29 -56.14 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 109.768 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -59.13 -32.71 70.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.126 -0.984 . . . . 0.0 109.022 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.07 -59.6 2.81 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.405 -0.809 . . . . 0.0 109.114 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.057 ' HA ' HG11 ' A' ' 28' ' ' VAL . 1.9 pp -57.83 -52.5 65.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.127 -0.983 . . . . 0.0 109.459 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.866 ' N ' HD12 ' A' ' 57' ' ' LEU . 12.5 p -51.39 -52.51 45.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.088 -1.008 . . . . 0.0 109.076 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' CG ' ' O ' ' A' ' 55' ' ' GLN . 11.1 mmtp -47.05 -46.96 22.69 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.284 -0.885 . . . . 0.0 108.965 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -47.94 81.21 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.632 HG22 ' HB1' ' A' ' 24' ' ' ALA . 68.6 p -56.44 -51.29 68.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 108.809 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.773 ' HB2' ' HB3' ' A' ' 67' ' ' PRO . . . -53.19 -37.12 61.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.357 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.01 -32.72 74.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.537 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.86 -2.34 23.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.489 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.0 -35.13 5.18 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' HB3' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -115.67 123.29 31.5 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.241 -1.152 . . . . 0.0 109.198 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.773 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 1.8 Cg_endo -114.72 -159.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.621 1.327 . . . . 0.0 111.021 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' HD21 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -152.29 -159.25 0.99 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.479 -0.763 . . . . 0.0 109.675 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 15.3 m -164.28 173.64 12.06 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.461 -0.774 . . . . 0.0 109.039 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . 7.4 p -90.11 146.5 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.945 -1.097 . . . . 0.0 109.813 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 6' ' ' THR . 3.1 tttt -150.87 126.07 9.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 0.0 109.462 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.435 -179.94 . . . . . . . . 0 0 . 1 stop_ save_